{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:21Z","timestamp":1792790541905,"version":"4.5.0"},"reference-count":408,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10555-019-09829-x","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T17:02:51Z","timestamp":1576602171000},"page":"783-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["MicroRNA dysregulation interplay with childhood abdominal tumors"],"prefix":"10.1007","volume":"38","author":[{"given":"Karina Bezerra","family":"Salom\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Alejandra","family":"Pezuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella Ribeiro","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Campos","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis Terci","family":"Valera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Sol","family":"Brassesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"issue":"3","key":"9829_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2013.04.003","volume":"153","author":"Luke\u00a0A. Yates","year":"2013","unstructured":"Yates, L. A. A., Norbury, C. J. J., & Gilbert, R. J. C. J. C. (2013). The long and short of microRNA. Cell, 153(3), 516\u2013519. https:\/\/doi.org\/10.1016\/j.cell.2013.04.003","journal-title":"Cell"},{"issue":"8","key":"9829_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"Minju Ha","year":"2014","unstructured":"Ha, M., & Kim, V. N. (2014). Regulation of microRNA biogenesis, 15(8). https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"9829_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cell.2007.12.024","volume":"132","author":"Ana Eulalio","year":"2008","unstructured":"Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008). Getting to the root of miRNA-mediated gene silencing. Cell, 132(1), 9\u201314. https:\/\/doi.org\/10.1016\/j.cell.2007.12.024","journal-title":"Cell"},{"issue":"1","key":"9829_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"R. C. Friedman","year":"2008","unstructured":"Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19(1), 92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108","journal-title":"Genome Research"},{"issue":"28","key":"9829_CR5","doi-asserted-by":"publisher","first-page":"E2851","DOI":"10.1073\/pnas.1407777111","volume":"111","author":"J. Wu","year":"2014","unstructured":"Wu, J., Bao, J., Kim, M., Yuan, S., Tang, C., Zheng, H., \u2026 Yan, W. (2014). Two miRNA clusters, miR-34b\/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis, 111(28). https:\/\/doi.org\/10.1073\/pnas.1407777111","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"9829_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/imr.12060","volume":"253","author":"Chang-Zheng Chen","year":"2013","unstructured":"Chen, C.-Z., Schaffert, S., Fragoso, R., & Loh, C. (2013). Regulation of immune responses and tolerance: the microRNA perspective, 253(1). https:\/\/doi.org\/10.1111\/imr.12060","journal-title":"Immunological Reviews"},{"issue":"24","key":"9829_CR7","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1007\/s00018-014-1700-6","volume":"71","author":"Garyfallia Papaioannou","year":"2014","unstructured":"Papaioannou, G., Mirzamohammadi, F., & Kobayashi, T. (2014). MicroRNAs involved in bone formation, 71(24). https:\/\/doi.org\/10.1007\/s00018-014-1700-6","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9829_CR8","doi-asserted-by":"publisher","unstructured":"Follert, P., Cremer, H., & B\u00e9clin, C. (2014). MicroRNAs in brain development and function: a matter of flexibility and stability, 7, 5. https:\/\/doi.org\/10.3389\/fnmol.2014.00005","DOI":"10.3389\/fnmol.2014.00005"},{"issue":"10","key":"9829_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/CIRCRESAHA.116.304377","volume":"116","author":"Conrad P. Hodgkinson","year":"2015","unstructured":"Hodgkinson, C. P., Kang, M. H., Dal-Pra, S., Mirotsou, M., & Dzau, V. J. (2015). MicroRNAs and cardiac regeneration, 116(10). https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304377","journal-title":"Circulation Research"},{"issue":"7385","key":"9829_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"Amaia Lujambio","year":"2012","unstructured":"Lujambio, A., & Lowe, S. W. (2012). The microcosmos of cancer. Nature, 482(7385). https:\/\/doi.org\/10.1038\/nature10888","journal-title":"Nature"},{"issue":"2","key":"9829_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1542\/PIR.2017-0057","volume":"39","author":"Wendy Allen-Rhoades","year":"2018","unstructured":"Allen-Rhoades, W., Whittle, S. B., & Rainusso, N. (2018). Pediatric solid tumors of infancy: an overview. Pediatrics in Review, 39(2), 57\u201367. https:\/\/doi.org\/10.1542\/PIR.2017-0057","journal-title":"Pediatrics in Review"},{"issue":"8","key":"9829_CR12","doi-asserted-by":"publisher","first-page":"e5984","DOI":"10.1097\/MD.0000000000005984","volume":"96","author":"Ilaria Amodeo","year":"2017","unstructured":"Amodeo, I., Cavallaro, G., Raffaeli, G., Colombo, L., Fumagalli, M., Cavalli, R., \u2026 Mosca, F. (2017). Abdominal cystic lymphangioma in a term newborn: a case report and update of new treatments. Medicine, 96(8), e5984. https:\/\/doi.org\/10.1097\/MD.0000000000005984","journal-title":"Medicine"},{"issue":"28","key":"9829_CR13","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.3748\/wjg.v21.i28.8541","volume":"21","author":"Liliana Chiorean","year":"2015","unstructured":"Chiorean, L. (2015). Benign liver tumors in pediatric patients - review with emphasis on imaging features. World Journal of Gastroenterology, 21(28), 8541. https:\/\/doi.org\/10.3748\/wjg.v21.i28.8541","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"9829_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/2249-4847.109246","volume":"2","author":"Jyotindu Debnath","year":"2013","unstructured":"Debnath, J., Pandit, A., Roy, S., & Sahoo, S. (2013). Congenital giant hydronephrosis: a rare cause for upper abdominal mass in the newborn. Journal of Clinical Neonatology, 2(1), 33. https:\/\/doi.org\/10.4103\/2249-4847.109246","journal-title":"Journal of Clinical Neonatology"},{"key":"9829_CR15","doi-asserted-by":"crossref","unstructured":"Brodeur, A. E., & Brodeur, G. M. (1991). Abdominal masses in children: neuroblastoma, Wilms tumor, and other considerations. Pediatrics in review, 12(7), 196\u2013207. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1846958","DOI":"10.1542\/pir.12-7-196"},{"issue":"3-4","key":"9829_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ncrna.2017.12.002","volume":"2","author":"Grace T. Kwok","year":"2017","unstructured":"Kwok, G. T., Zhao, J. T., Weiss, J., Mugridge, N., Brahmbhatt, H., MacDiarmid, J. A., \u2026 Sidhu, S. B. (2017). Translational applications of microRNAs in cancer, and therapeutic implications. Non-coding RNA Research, 2(3\u20134), 143\u2013150. https:\/\/doi.org\/10.1016\/j.ncrna.2017.12.002","journal-title":"Non-coding RNA Research"},{"issue":"10","key":"9829_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"Xi Chen","year":"2008","unstructured":"Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., \u2026 Zhang, C.-Y. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, 18(10), 997\u20131006. https:\/\/doi.org\/10.1038\/cr.2008.282","journal-title":"Cell Research"},{"issue":"1","key":"9829_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2009.09.061","volume":"390","author":"M. Mraz","year":"2009","unstructured":"Mraz, M., Malinova, K., Mayer, J., & Pospisilova, S. (2009). MicroRNA isolation and stability in stored RNA samples, 390(1), 1\u20134. https:\/\/doi.org\/10.1016\/j.bbrc.2009.09.061","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"10","key":"9829_CR19","doi-asserted-by":"publisher","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","volume":"3","author":"Ming Lu","year":"2008","unstructured":"Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W., & Cui, Q. (2008). An analysis of human microRNA and disease associations. PLoS ONE, 3(10), e3420. https:\/\/doi.org\/10.1371\/journal.pone.0003420","journal-title":"PLoS ONE"},{"issue":"9","key":"9829_CR20","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"G. A. Calin","year":"2004","unstructured":"Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., \u2026 Croce, C. M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, 101(9), 2999\u20133004. https:\/\/doi.org\/10.1073\/pnas.0307323101","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"17","key":"9829_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1056\/NEJMp058190","volume":"353","author":"Chang-Zheng Chen","year":"2005","unstructured":"Chen, C.-Z. (2005). MicroRNAs as oncogenes and tumor suppressors. New England Journal of Medicine, 353(17), 1768\u20131771. https:\/\/doi.org\/10.1056\/NEJMp058190","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"9829_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2217\/epi.15.6","volume":"7","author":"Lu Qian Wang","year":"2015","unstructured":"Wang, L. Q., & Chim, C. S. (2015). DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics, 7(3), 461\u2013473. https:\/\/doi.org\/10.2217\/epi.15.6","journal-title":"Epigenomics"},{"key":"9829_CR23","doi-asserted-by":"crossref","unstructured":"Kian, R., Moradi, S., & Ghorbian, S. (2018). Role of components of microRNA machinery in carcinogenesis. Experimental oncology, 40(1), 2\u20139. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29600985","DOI":"10.31768\/2312-8852.2018.40(1):2-9"},{"issue":"2","key":"9829_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/path.4196","volume":"230","author":"MK Wu","year":"2013","unstructured":"Wu, M., Sabbaghian, N., Xu, B., Addidou-Kalucki, S., Bernard, C., Zou, D., \u2026 Foulkes, W. (2013). Biallelic DICER1mutations occur in Wilms tumours. The Journal of Pathology, 230(2), 154\u2013164. https:\/\/doi.org\/10.1002\/path.4196","journal-title":"The Journal of Pathology"},{"issue":"10","key":"9829_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrc3802","volume":"14","author":"William D. Foulkes","year":"2014","unstructured":"Foulkes, W. D., Priest, J. R., & Duchaine, T. F. (2014). DICER1: mutations, microRNAs and mechanisms, 14(10). https:\/\/doi.org\/10.1038\/nrc3802","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"9829_CR26","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1530\/ERC-17-0509","volume":"25","author":"Michael Solarski","year":"2018","unstructured":"Solarski, M., Rotondo, F., Foulkes, W. D., Priest, J. R., Syro, L. V, Butz, H., \u2026 Kovacs, K. (2018). DICER1 gene mutations in endocrine tumors. Endocrine-Related Cancer, 25(3), R197\u2013R208. https:\/\/doi.org\/10.1530\/ERC-17-0509","journal-title":"Endocrine-Related Cancer"},{"key":"9829_CR27","doi-asserted-by":"publisher","unstructured":"Mathew, P., Valentine, M. B., Bowman, L. C., Rowe, S. T., Nash, M. B., Valentine, V. A., \u2026 Look, A. T. (2001). Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. Neoplasia (New York, N.Y.), 3(2), 105\u20139. https:\/\/doi.org\/10.1038\/sj\/neo\/7900146","DOI":"10.1038\/sj\/neo\/7900146"},{"issue":"3","key":"9829_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"Garrett M. Brodeur","year":"2003","unstructured":"Brodeur, G. M. (2003). Neuroblastoma: biological insights into a clinical enigma, 3(3). https:\/\/doi.org\/10.1038\/nrc1014","journal-title":"Nature Reviews Cancer"},{"issue":"5","key":"9829_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1541-7786.MCR-07-2102","volume":"6","author":"K. A. Cole","year":"2008","unstructured":"Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., & Maris, J. M. (2008). A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Molecular cancer research: MCR, 6(5), 735\u201342. https:\/\/doi.org\/10.1158\/1541-7786.MCR-07-2102","journal-title":"Molecular Cancer Research"},{"issue":"34","key":"9829_CR30","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1038\/sj.onc.1210293","volume":"26","author":"C Welch","year":"2007","unstructured":"Welch, C., Chen, Y., & Stallings, R. L. (2007). MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 26(34). https:\/\/doi.org\/10.1038\/sj.onc.1210293","journal-title":"Oncogene"},{"issue":"39","key":"9829_CR31","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1038\/onc.2008.154","volume":"27","author":"J S Wei","year":"2008","unstructured":"Wei, J. S., Song, Y. K., Durinck, S., Chen, Q.-R., Cheuk, A. T. C., Tsang, P., \u2026 Khan, J. (2008). The MYCN oncogene is a direct target of miR-34a. Oncogene, 27(39). https:\/\/doi.org\/10.1038\/onc.2008.154","journal-title":"Oncogene"},{"issue":"2","key":"9829_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/bjc.2011.220","volume":"105","author":"J Buechner","year":"2011","unstructured":"Buechner, J., T\u00f8mte, E., Haug, B. H., Henriksen, J. R., L\u00f8kke, C., Fl\u00e6gstad, T., & Einvik, C. (2011). Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. British Journal of Cancer, 105(2), 296\u2013303. https:\/\/doi.org\/10.1038\/bjc.2011.220","journal-title":"British Journal of Cancer"},{"key":"9829_CR33","doi-asserted-by":"crossref","unstructured":"Wang, L., Che, X.-J., Wang, N., Li, J., & Zhu, M.-H. (2014). Regulatory network analysis of microRNAs and genes in neuroblastoma. Asian Pacific journal of cancer prevention: APJCP, 15(18), 7645\u201352. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25292042","DOI":"10.7314\/APJCP.2014.15.18.7645"},{"key":"9829_CR34","doi-asserted-by":"publisher","unstructured":"Tivnan, A., Tracey, L., Buckley, P. G., Alcock, L. C., Davidoff, A. M., & Stallings, R. L. (2011). MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma, 11(1), 33. https:\/\/doi.org\/10.1186\/1471-2407-11-33","DOI":"10.1186\/1471-2407-11-33"},{"issue":"8","key":"9829_CR35","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1074\/mcp.M113.035808","volume":"13","author":"Pasqualino De Antonellis","year":"2014","unstructured":"De Antonellis, P., Carotenuto, M., Vandenbussche, J., De Vita, G., Ferrucci, V., Medaglia, C., \u2026 Zollo, M. (2014). Early targets of miR-34a in neuroblastoma, 13(8). https:\/\/doi.org\/10.1074\/mcp.M113.035808","journal-title":"Molecular & Cellular Proteomics"},{"key":"9829_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2019.01.071","volume":"850","author":"Xinru Cheng","year":"2019","unstructured":"Cheng, X., Xu, Q., Zhang, Y., Shen, M., Zhang, S., Mao, F., \u2026 Zhang, Q. (2019). miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5. European Journal of Pharmacology, 53\u201363. https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.071","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"9829_CR37","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-16-1591","volume":"23","author":"Xiao-yan He","year":"2016","unstructured":"He, X.-Y., Tan, Z.-L., Mou, Q., Liu, F.-J., Liu, S., Yu, C., \u2026 Zou, L. (2017). microRNA-221 enhances MYCN via targeting Nemo-like kinase and functions as an oncogene related to poor prognosis in neuroblastoma, 23(11), 2905\u20132918. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1591","journal-title":"Clinical Cancer Research"},{"issue":"13","key":"9829_CR38","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-12-2681","volume":"73","author":"Tal Teitz","year":"2013","unstructured":"Teitz, T., Inoue, M., Valentine, M. B., Zhu, K., Rehg, J. E., Zhao, W., \u2026 Lahti, J. M. (2013). Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis. Cancer Research, 73(13), 4086\u20134097. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2681","journal-title":"Cancer Research"},{"key":"9829_CR39","doi-asserted-by":"publisher","unstructured":"Xin, C., Buhe, B., Hongting, L., Chuanmin, Y., Xiwei, H., Hong, Z., \u2026 Renjie, W. (2013). MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression, 280(3). https:\/\/doi.org\/10.1111\/febs.12074","DOI":"10.1111\/febs.12074"},{"issue":"7","key":"9829_CR40","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1158\/1535-7163.MCT-12-0001","volume":"11","author":"H. Zhang","year":"2012","unstructured":"Zhang, H., Qi, M., Li, S., Qi, T., Mei, H., Huang, K., \u2026 Tong, Q. (2012). microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Molecular cancer therapeutics, 11(7), 1454\u201366. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0001","journal-title":"Molecular Cancer Therapeutics"},{"issue":"9","key":"9829_CR41","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.bbadis.2015.06.002","volume":"1852","author":"Xuan Xiang","year":"2015","unstructured":"Xiang, X., Mei, H., Qu, H., Zhao, X., Li, D., Song, H., \u2026 Tong, Q. (2015). miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1852(9), 1743\u20131754. Retrieved from https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0925443915001660","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"5","key":"9829_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.molcel.2010.11.038","volume":"40","author":"Pieter Mestdagh","year":"2010","unstructured":"Mestdagh, P., Bostr\u00f6m, A.-K., Impens, F., Fredlund, E., Van Peer, G., De Antonellis, P., \u2026 Vandesompele, J. (2010). The miR-17-92 microRNA cluster regulates multiple components of the TGF-\u03b2 pathway in neuroblastoma. Molecular Cell, 40(5), 762\u2013773. https:\/\/doi.org\/10.1016\/j.molcel.2010.11.038","journal-title":"Molecular Cell"},{"issue":"5","key":"9829_CR43","doi-asserted-by":"publisher","first-page":"e2236","DOI":"10.1371\/journal.pone.0002236","volume":"3","author":"Laura Fontana","year":"2008","unstructured":"Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., \u2026 Fruci, D. (2008). Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM, 3(5), e2236. https:\/\/doi.org\/10.1371\/journal.pone.0002236","journal-title":"PLoS ONE"},{"issue":"17","key":"9829_CR44","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1093\/nar\/gkq342","volume":"38","author":"Johannes H. Schulte","year":"2010","unstructured":"Schulte, J. H., Marschall, T., Martin, M., Rosenstiel, P., Mestdagh, P., Schlierf, S., \u2026 Schramm, A. (2010). Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Research, 38(17), 5919\u20135928. https:\/\/doi.org\/10.1093\/nar\/gkq342","journal-title":"Nucleic Acids Research"},{"issue":"11","key":"9829_CR45","doi-asserted-by":"publisher","first-page":"e7850","DOI":"10.1371\/journal.pone.0007850","volume":"4","author":"Isabella Bray","year":"2009","unstructured":"Bray, I., Bryan, K., Prenter, S., Buckley, P. G., Foley, N. H., Murphy, D. M., \u2026 Stallings, R. L. (2009). Widespread dysregulation of miRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. PLoS ONE, 4(11), e7850. https:\/\/doi.org\/10.1371\/journal.pone.0007850","journal-title":"PLoS ONE"},{"issue":"4","key":"9829_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.celrep.2016.06.052","volume":"16","author":"Diogo Ribeiro","year":"2016","unstructured":"Ribeiro, D., Klarqvist, M. D. R., Westermark, U. K., Oliynyk, G., Dzieran, J., Kock, A., \u2026 Arsenian Henriksson, M. (2016). Regulation of nuclear hormone receptors by MYCN-driven miRNAs impacts neural differentiation and survival in neuroblastoma patients. Cell Reports, 16(4), 979\u2013993. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.052","journal-title":"Cell Reports"},{"issue":"11","key":"9829_CR47","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1002\/ijc.26295","volume":"130","author":"Sara De Brouwer","year":"2011","unstructured":"De Brouwer, S., Mestdagh, P., Lambertz, I., Pattyn, F., De Paepe, A., Westermann, F., Speleman, F. (2012). Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma, 130(11). https:\/\/doi.org\/10.1002\/ijc.26295","journal-title":"International Journal of Cancer"},{"issue":"7","key":"9829_CR48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/carcin\/bgr073","volume":"32","author":"Bj\u00f8rn Helge Haug","year":"2011","unstructured":"Haug, B. H., Henriksen, J. R., Buechner, J., Geerts, D., T\u00f8mte, E., Kogner, P., \u2026 Einvik, C. (2011). MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis, 32(7), 1005\u20131012. https:\/\/doi.org\/10.1093\/carcin\/bgr073","journal-title":"Carcinogenesis"},{"issue":"4","key":"9829_CR49","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1073\/pnas.0913517107","volume":"107","author":"J. Loven","year":"2010","unstructured":"Lov\u00e9n, J., Zinin, N., Wahlstr\u00f6m, T., M\u00fcller, I., Brodin, P., Fredlund, E., \u2026 Henriksson, M. (2010). MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America, 107(4), 1553\u20138. https:\/\/doi.org\/10.1073\/pnas.0913517107","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"9829_CR50","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s13277-013-0777-0","volume":"34","author":"Julie Bienertova-Vasku","year":"2013","unstructured":"Bienertova-Vasku, J., Mazanek, P., Hezova, R., Curdova, A., Nekvindova, J., Kren, L., Slaby, O. (2013). Extension of microRNA expression pattern associated with high-risk neuroblastoma. Tumor Biology, 34(4), 2315\u20132319. https:\/\/doi.org\/10.1007\/s13277-013-0777-0","journal-title":"Tumor Biology"},{"key":"9829_CR51","doi-asserted-by":"publisher","unstructured":"Naraparaju, K., Kolla, V., Zhuang, T., Higashi, M., Iyer, R., Kolla, S., \u2026 Brodeur, G. M. (2016). Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget, 7(13), 15977\u201385. https:\/\/doi.org\/10.18632\/oncotarget.7434","DOI":"10.18632\/oncotarget.7434"},{"issue":"1","key":"9829_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/107327481602300113","volume":"23","author":"Yaodong Zhou","year":"2016","unstructured":"Zhou, Y., & Sheng, B. (2016). Association of microRNA 21 with biological features and prognosis of neuroblastoma. Cancer control: journal of the Moffitt Cancer Center, 23(1), 78\u201384. https:\/\/doi.org\/10.1177\/107327481602300113","journal-title":"Cancer Control"},{"issue":"10","key":"9829_CR53","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jpedsurg.2012.05.013","volume":"47","author":"Yun Chen","year":"2012","unstructured":"Chen, Y., Tsai, Y.-H., Fang, Y., & Tseng, S.-H. (2012). Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells, 47(10). https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.05.013","journal-title":"Journal of Pediatric Surgery"},{"issue":"8","key":"9829_CR54","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm1699","volume":"6","author":"Barry M. Gumbiner","year":"2005","unstructured":"Gumbiner, B. M. (2005). Regulation of cadherin-mediated adhesion in morphogenesis. Nature Reviews Molecular Cell Biology, 6(8), 622\u2013634. https:\/\/doi.org\/10.1038\/nrm1699","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"9829_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3892\/ol.2014.1794","volume":"7","author":"LIN CHENG","year":"2014","unstructured":"Cheng, L., Yang, T., Kuang, Y., Kong, B., Yu, S., Shu, H., \u2026 Gu, J. (2014). MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1. Oncology letters, 7(3), 839\u2013845. https:\/\/doi.org\/10.3892\/ol.2014.1794","journal-title":"Oncology Letters"},{"key":"9829_CR56","doi-asserted-by":"publisher","unstructured":"Khan, F. H., Pandian, V., Ramraj, S., Aravindan, S., Herman, T. S., & Aravindan, N. (2015). Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells. BMC Genomics, 16(1), 501. https:\/\/doi.org\/10.1186\/s12864-015-1642-x","DOI":"10.1186\/s12864-015-1642-x"},{"key":"9829_CR57","doi-asserted-by":"publisher","unstructured":"Maugeri, M., Barbagallo, D., Barbagallo, C., Banelli, B., Di Mauro, S., Purrello, F., \u2026 Purrello, M. (2016). Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma. Oncotarget, 7(50), 83330\u201383341. https:\/\/doi.org\/10.18632\/oncotarget.13090","DOI":"10.18632\/oncotarget.13090"},{"issue":"10","key":"9829_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/gcc.22189","volume":"53","author":"Irene Y. Cheung","year":"2014","unstructured":"Cheung, I. Y., Farazi, T. A., Ostrovnaya, I., Xu, H., Tran, H., Mihailovic, A., \u2026 Cheung, N.-K. V. (2014). Deep microRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis, 53(10). https:\/\/doi.org\/10.1002\/gcc.22189","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"12","key":"9829_CR59","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.bbagrm.2016.10.006","volume":"1859","author":"Federica Parodi","year":"2016","unstructured":"Parodi, F., Carosio, R., Ragusa, M., Di Pietro, C., Maugeri, M., Barbagallo, D., \u2026 Banelli, B. (2016). Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1859(12), 1502\u20131514. https:\/\/doi.org\/10.1016\/j.bbagrm.2016.10.006","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"issue":"22","key":"9829_CR60","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.febslet.2011.10.025","volume":"585","author":"Tsui-Chin Huang","year":"2011","unstructured":"Huang, T.-C., Chang, H.-Y., Chen, C.-Y., Wu, P.-Y., Lee, H., Liao, Y.-F., \u2026 Juan, H.-F. (2011). Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR, 585(22). https:\/\/doi.org\/10.1016\/j.febslet.2011.10.025","journal-title":"FEBS Letters"},{"key":"9829_CR61","doi-asserted-by":"publisher","unstructured":"Zhao, Z., Ma, X., Shelton, S. D., Sung, D. C., Li, M., Hernandez, D., \u2026 Du, L. (2016). A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells. Oncotarget, 7(48), 79372\u201379387. https:\/\/doi.org\/10.18632\/oncotarget.12676","DOI":"10.18632\/oncotarget.12676"},{"key":"9829_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.csbj.2015.04.003","volume":"13","author":"Duncan Ayers","year":"2015","unstructured":"Ayers, D., Mestdagh, P., Van Maerken, T., & Vandesompele, J. (2015). Identification of miRNAs contributing to neuroblastoma chemoresistance, 13. https:\/\/doi.org\/10.1016\/j.csbj.2015.04.003","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"28","key":"9829_CR63","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1038\/onc.2013.330","volume":"33","author":"A A Takwi","year":"2013","unstructured":"Takwi, A. A., Wang, Y.-M., Wu, J., Michaelis, M., Cinatl, J., & Chen, T. (2014). miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene, 33(28). https:\/\/doi.org\/10.1038\/onc.2013.330","journal-title":"Oncogene"},{"key":"9829_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2017.02.035","volume":"802","author":"Gang Zhao","year":"2017","unstructured":"Zhao, G., Wang, G., Bai, H., Li, T., Gong, F., Yang, H., \u2026 Wang, W. (2017). Targeted inhibition of HDAC8 increases the doxorubicin sensitivity of neuroblastoma cells via up regulation of miR-137. European journal of pharmacology, 802, 20\u201326. https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.035","journal-title":"European Journal of Pharmacology"},{"issue":"10","key":"9829_CR65","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.yexcr.2013.02.025","volume":"319","author":"Mrinmay Chakrabarti","year":"2013","unstructured":"Chakrabarti, M., Banik, N. L., & Ray, S. K. (2013). miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo, 319(10). https:\/\/doi.org\/10.1016\/j.yexcr.2013.02.025","journal-title":"Experimental Cell Research"},{"issue":"12","key":"9829_CR66","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00383-010-2700-8","volume":"26","author":"Tetsuya Yamagata","year":"2010","unstructured":"Yamagata, T., Yoshizawa, J., Ohashi, S., Yanaga, K., & Ohki, T. (2010). Expression patterns of microRNAs are altered in hypoxic human neuroblastoma cells, 26(12). https:\/\/doi.org\/10.1007\/s00383-010-2700-8","journal-title":"Pediatric Surgery International"},{"issue":"3","key":"9829_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/onc.2012.574","volume":"33","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Pu, J., Qi, T., Qi, M., Yang, C., Li, S., \u2026 Tong, Q. (2014). MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene, 33(3). https:\/\/doi.org\/10.1038\/onc.2012.574","journal-title":"Oncogene"},{"key":"9829_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2017.04.011","volume":"139","author":"Yali Xu","year":"2017","unstructured":"Xu, Y., Chen, X., Lin, L., Chen, H., Yu, S., & Li, D. (2017). MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification. Biochimie, 139, 1\u20138. https:\/\/doi.org\/10.1016\/j.biochi.2017.04.011","journal-title":"Biochimie"},{"key":"9829_CR69","doi-asserted-by":"publisher","unstructured":"Lin, R.-J., Lin, Y.-C., & Yu, A. L. (2010). miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells, 49(8). https:\/\/doi.org\/10.1002\/mc.20647","DOI":"10.1002\/mc.20647"},{"issue":"20","key":"9829_CR70","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1158\/0008-5472.CAN-10-1534","volume":"70","author":"S. Das","year":"2010","unstructured":"Das, S., Foley, N., Bryan, K., Watters, K. M., Bray, I., Murphy, D. M., \u2026 Stallings, R. L. (2010). MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Research, 70(20), 7874\u20137881. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1534","journal-title":"Cancer Research"},{"key":"9829_CR71","doi-asserted-by":"publisher","unstructured":"Gibert, B., Delloye-Bourgeois, C., Gattolliat, C.-H., Meurette, O., Le Guernevel, S., Fombonne, J., \u2026 Mehlen, P. (2014). Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma. JNCI: Journal of the National Cancer Institute, 106(11). https:\/\/doi.org\/10.1093\/jnci\/dju318","DOI":"10.1093\/jnci\/dju318"},{"issue":"1","key":"9829_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/abbs\/gmt124","volume":"46","author":"Y. Li","year":"2013","unstructured":"Li, Y., Wang, H., Li, J., & Yue, W. (2014). MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7. Acta Biochimica et Biophysica Sinica, 46(1), 48\u201355. https:\/\/doi.org\/10.1093\/abbs\/gmt124","journal-title":"Acta Biochimica et Biophysica Sinica"},{"issue":"7","key":"9829_CR73","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1021\/acs.jproteome.6b00134","volume":"15","author":"Marco Lodrini","year":"2016","unstructured":"Lodrini, M., Poschmann, G., Schmidt, V., W\u00fcnschel, J., Dreidax, D., Witt, O., \u2026 Deubzer, H. E. (2016). Minichromosome maintenance complex is a critical node in the miR-183 signaling network of MYCN -amplified neuroblastoma cells. Journal of Proteome Research, 15(7), 2178\u20132186. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00134","journal-title":"Journal of Proteome Research"},{"issue":"12","key":"9829_CR74","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1093\/nar\/gkt346","volume":"41","author":"Marco Lodrini","year":"2013","unstructured":"Lodrini, M., Oehme, I., Schroeder, C., Milde, T., Schier, M. C., Kopp-Schneider, A., \u2026 Deubzer, H. E. (2013). MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma, 41(12). https:\/\/doi.org\/10.1093\/nar\/gkt346","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"9829_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1476-4598-9-83","volume":"9","author":"Niamh H Foley","year":"2010","unstructured":"Foley, N. H., Bray, I. M., Tivnan, A., Bryan, K., Murphy, D. M., Buckley, P. G., \u2026 Stallings, R. L. (2010). MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine\/threonine kinase AKT2. Molecular Cancer, 9(1), 83. https:\/\/doi.org\/10.1186\/1476-4598-9-83","journal-title":"Molecular Cancer"},{"issue":"3","key":"9829_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.mehy.2012.11.033","volume":"80","author":"Ondrej Slaby","year":"2013","unstructured":"Slaby, O. (2013). MiR-190 leads to aggressive phenotype of neuroblastoma through indirect activation of TrkB pathway, 80(3). https:\/\/doi.org\/10.1016\/j.mehy.2012.11.033","journal-title":"Medical Hypotheses"},{"issue":"11","key":"9829_CR77","doi-asserted-by":"publisher","first-page":"e78713","DOI":"10.1371\/journal.pone.0078713","volume":"8","author":"Galina Feinberg-Gorenshtein","year":"2013","unstructured":"Feinberg-Gorenshtein, G., Guedj, A., Shichrur, K., Jeison, M., Luria, D., Kodman, Y., \u2026 Avigad, S. (2013). miR-192 directly binds and regulates Dicer1 expression in neuroblastoma. PLoS ONE, 8(11), e78713. https:\/\/doi.org\/10.1371\/journal.pone.0078713","journal-title":"PLoS ONE"},{"key":"9829_CR78","doi-asserted-by":"publisher","unstructured":"Roth, S. A., Hald, \u00d8. H., Fuchs, S., L\u00f8kke, C., Mikkola, I., Fl\u00e6gstad, T., \u2026 Einvik, C. (2018). MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. Oncotarget, 9(26), 18160\u201318179. https:\/\/doi.org\/10.18632\/oncotarget.24793","DOI":"10.18632\/oncotarget.24793"},{"issue":"24","key":"9829_CR79","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1038\/onc.2012.311","volume":"32","author":"S Das","year":"2012","unstructured":"Das, S., Bryan, K., Buckley, P. G., Piskareva, O., Bray, I. M., Foley, N., \u2026 Stallings, R. L. (2013). Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene, 32(24). https:\/\/doi.org\/10.1038\/onc.2012.311","journal-title":"Oncogene"},{"key":"9829_CR80","doi-asserted-by":"crossref","unstructured":"Gao, S.-L., Wang, L.-Z., Liu, H.-Y., Liu, D.-L., Xie, L.-M., & Zhang, Z.-W. (2014). miR-200a inhibits tumor proliferation by targeting AP-2\u03b3 in neuroblastoma cells. Asian Pacific journal of cancer prevention: APJCP, 15(11), 4671\u20136. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24969902","DOI":"10.7314\/APJCP.2014.15.11.4671"},{"issue":"6","key":"9829_CR81","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/bjc.2012.356","volume":"107","author":"J Ryan","year":"2012","unstructured":"Ryan, J., Tivnan, A., Fay, J., Bryan, K., Meehan, M., Creevey, L., \u2026 Stallings, R. L. (2012). MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome, 107(6). https:\/\/doi.org\/10.1038\/bjc.2012.356","journal-title":"British Journal of Cancer"},{"key":"9829_CR82","doi-asserted-by":"publisher","unstructured":"Ooi, C. Y., Carter, D. R., Liu, B., Mayoh, C., Beckers, A., Lalwani, A., \u2026 Marshall, G. M. (2018). Network modeling of microRNA\u2013mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN. Cancer Research, 78(12), 3122\u20133134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3034","DOI":"10.1158\/0008-5472.CAN-17-3034"},{"issue":"1","key":"9829_CR83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.febslet.2013.11.036","volume":"588","author":"Haifeng Yang","year":"2013","unstructured":"Yang, H., Li, Q., Zhao, W., Yuan, D., Zhao, H., & Zhou, Y. (2014). miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A, 588(1). https:\/\/doi.org\/10.1016\/j.febslet.2013.11.036","journal-title":"FEBS Letters"},{"issue":"11","key":"9829_CR84","doi-asserted-by":"publisher","first-page":"e78428","DOI":"10.1371\/journal.pone.0078428","volume":"8","author":"Jennifer Lynch","year":"2013","unstructured":"Lynch, J., Meehan, M. H., Crean, J., Copeland, J., Stallings, R. L., & Bray, I. M. (2013). Metastasis suppressor microRNA-335 targets the formin family of actin nucleators, 8(11), e78428. https:\/\/doi.org\/10.1371\/journal.pone.0078428","journal-title":"PLoS ONE"},{"issue":"22","key":"9829_CR85","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1016\/j.febslet.2013.09.044","volume":"587","author":"Xin Chen","year":"2013","unstructured":"Chen, X., Pan, M., Han, L., Lu, H., Hao, X., & Dong, Q. (2013). miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Letters, 587(22), 3729\u20133737. https:\/\/doi.org\/10.1016\/j.febslet.2013.09.044","journal-title":"FEBS Letters"},{"issue":"15","key":"9829_CR86","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/J.FEBSLET.2015.05.056","volume":"589","author":"Kai Wu","year":"2015","unstructured":"Wu, K., Yang, L., Chen, J., Zhao, H., Wang, J., Xu, S., & Huang, Z. (2015). miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2\u03b2. FEBS Letters, 589(15), 1911\u20131919. https:\/\/doi.org\/10.1016\/J.FEBSLET.2015.05.056","journal-title":"FEBS Letters"},{"issue":"2","key":"9829_CR87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3892\/mmr.2013.1845","volume":"9","author":"YU-GUANG LI","year":"2013","unstructured":"Li, Y.-G., He, J.-H., YU, L., Hang, Z.-P., LI, W., Shun, W.-H., & HUANG, G. X. (2014). microRNA-202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN-5, 9(2). https:\/\/doi.org\/10.3892\/mmr.2013.1845","journal-title":"Molecular Medicine Reports"},{"issue":"6","key":"9829_CR88","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1159\/000362952","volume":"33","author":"Chunhui Cui","year":"2014","unstructured":"Cui, C., Yu, J., Huang, S., Zhu, H., & Huang, Z. (2014). Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors, 33(6). https:\/\/doi.org\/10.1159\/000362952","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"10","key":"9829_CR89","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/nm.2227","volume":"16","author":"Alexander Swarbrick","year":"2010","unstructured":"Swarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y., Nguyen, A., \u2026 Goga, A. (2010). miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma, 16(10). https:\/\/doi.org\/10.1038\/nm.2227","journal-title":"Nature Medicine"},{"issue":"10","key":"9829_CR90","doi-asserted-by":"publisher","first-page":"10011","DOI":"10.1007\/s13277-014-1921-1","volume":"35","author":"Yu Li","year":"2014","unstructured":"Li, Y.-M. Y., Li, W., Zhang, J.-G., Li, H.-Y., & Li, Y.-M. Y. (2014). Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma. Tumor Biology, 35(10), 10011\u201310017. https:\/\/doi.org\/10.1007\/s13277-014-1921-1","journal-title":"Tumor Biology"},{"issue":"4","key":"9829_CR91","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1073\/pnas.0907763107","volume":"107","author":"H. Hu","year":"2010","unstructured":"Hu, H., Du, L., Nagabayashi, G., Seeger, R. C., & Gatti, R. A. (2010). ATM is down-regulated by N-Myc\u2013regulated microRNA-421, 107(4). https:\/\/doi.org\/10.1073\/pnas.0907763107","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"9829_CR92","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/15476286.2015.1023495","volume":"12","author":"Zhenze Zhao","year":"2015","unstructured":"Zhao, Z., Ma, X., Sung, D., Li, M., Kosti, A., Lin, G., \u2026 Du, L. (2015). microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. RNA biology, 12(5), 538\u201354. https:\/\/doi.org\/10.1080\/15476286.2015.1023495","journal-title":"RNA Biology"},{"issue":"3","key":"9829_CR93","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3892\/mmr.2016.4770","volume":"13","author":"GENG LIU","year":"2016","unstructured":"Liu, G., Xu, Z., & Hao, D. (2016). MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor. Molecular medicine reports, 13(3), 2253\u201360. https:\/\/doi.org\/10.3892\/mmr.2016.4770","journal-title":"Molecular Medicine Reports"},{"issue":"4","key":"9829_CR94","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/cam4.264","volume":"3","author":"Charles-Henry Gattolliat","year":"2014","unstructured":"Gattolliat, C.-H., Le Teuff, G., Combaret, V., Mussard, E., Valteau-Couanet, D., Busson, P., \u2026 Douc-Rasy, S. (2014). Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients, 3(4), 998\u20131009. https:\/\/doi.org\/10.1002\/cam4.264","journal-title":"Cancer Medicine"},{"issue":"1","key":"9829_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-4598-12-23","volume":"12","author":"Laura Creevey","year":"2013","unstructured":"Creevey, L., Ryan, J., Harvey, H., Bray, I. M., Meehan, M., Khan, A. R., & Stallings, R. L. (2013). MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Molecular Cancer, 12(1), 23. https:\/\/doi.org\/10.1186\/1476-4598-12-23","journal-title":"Molecular Cancer"},{"key":"9829_CR96","doi-asserted-by":"publisher","unstructured":"Soriano, A., Par\u00eds-Coderch, L., Jubierre, L., Mart\u00ednez, A., Zhou, X., Piskareva, O., \u2026 Segura, M. F. (2016). MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget, 7(8), 9271\u201387. https:\/\/doi.org\/10.18632\/oncotarget.7005","DOI":"10.18632\/oncotarget.7005"},{"issue":"1","key":"9829_CR97","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/ol.2016.5442","volume":"13","author":"Dianguo Li","year":"2016","unstructured":"Li, D., Cao, Y., Li, J., Xu, J., Liu, Q., & Sun, X. (2017). miR-506 suppresses neuroblastoma metastasis by targeting ROCK1. Oncology letters, 13(1), 417\u2013422. https:\/\/doi.org\/10.3892\/ol.2016.5442","journal-title":"Oncology Letters"},{"issue":"7","key":"9829_CR98","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/ijc.29144","volume":"136","author":"Harry Harvey","year":"2014","unstructured":"Harvey, H., Piskareva, O., Creevey, L., Alcock, L. C., Buckley, P. G., O\u2019Sullivan, M. J., \u2026 Bray, I. M. (2015). Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f, 136(7). https:\/\/doi.org\/10.1002\/ijc.29144","journal-title":"International Journal of Cancer"},{"issue":"6","key":"9829_CR99","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/ijc.29091","volume":"136","author":"Kristina Althoff","year":"2014","unstructured":"Althoff, K., Lindner, S., Odersky, A., Mestdagh, P., Beckers, A., Karczewski, S., \u2026 Schulte, J. H. (2015). miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin, 136(6). https:\/\/doi.org\/10.1002\/ijc.29091","journal-title":"International Journal of Cancer"},{"issue":"1","key":"9829_CR100","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2011.01.016","volume":"303","author":"Isabella Bray","year":"2011","unstructured":"Bray, I., Tivnan, A., Bryan, K., Foley, N. H., Watters, K. M., Tracey, L., \u2026 Stallings, R. L. (2011). MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. Cancer Letters, 303(1), 56\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2011.01.016","journal-title":"Cancer Letters"},{"issue":"11","key":"9829_CR101","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1158\/0008-5472.CAN-10-4391","volume":"71","author":"J. M. Shohet","year":"2011","unstructured":"Shohet, J. M., Ghosh, R., Coarfa, C., Ludwig, A., Benham, A. L., Chen, Z., \u2026 Gunaratne, P. H. (2011). A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma, 71(11). https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4391","journal-title":"Cancer Research"},{"issue":"11","key":"9829_CR102","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1158\/1078-0432.CCR-09-3215","volume":"16","author":"P. G. Buckley","year":"2010","unstructured":"Buckley, P. G., Alcock, L., Bryan, K., Bray, I., Schulte, J. H., Schramm, A., \u2026 Stallings, R. L. (2010). Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma. Clinical Cancer Research, 16(11), 2971\u20132978. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-3215","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"9829_CR103","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2017.5701","volume":"38","author":"Francesca Megiorni","year":"2017","unstructured":"Megiorni, F., Colaiacovo, M., Cialfi, S., McDowell, H. P., Guffanti, A., Camero, S., \u2026 Dominici, C. (2017). A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma, 38(1), 3\u201320. https:\/\/doi.org\/10.3892\/or.2017.5701","journal-title":"Oncology Reports"},{"key":"9829_CR104","doi-asserted-by":"publisher","unstructured":"Stigliani, S., Scaruffi, P., Lagazio, C., Persico, L., Carlini, B., Varesio, L., \u2026 Corrias, M. V. (2015). Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients. Oncotarget, 6(15), 13295\u201313308. https:\/\/doi.org\/10.18632\/oncotarget.3745","DOI":"10.18632\/oncotarget.3745"},{"issue":"6","key":"9829_CR105","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/cdd.2010.164","volume":"18","author":"E A Afanasyeva","year":"2011","unstructured":"Afanasyeva, E. A., Mestdagh, P., Kumps, C., Vandesompele, J., Ehemann, V., Theissen, J., \u2026 Westermann, F. (2011). MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival, 18(6). https:\/\/doi.org\/10.1038\/cdd.2010.164","journal-title":"Cell Death & Differentiation"},{"key":"9829_CR106","doi-asserted-by":"publisher","unstructured":"Wu, T., Lin, Y., & Xie, Z. (2018). MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma. Biological research, 51(1), 13. https:\/\/doi.org\/10.1186\/s40659-018-0162-y","DOI":"10.1186\/s40659-018-0162-y"},{"issue":"12","key":"9829_CR107","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.cellsig.2009.07.019","volume":"21","author":"Natalie J. Beveridge","year":"2009","unstructured":"Beveridge, N. J., Tooney, P. A., Carroll, A. P., Tran, N., & Cairns, M. J. (2009). Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation, 21(12). https:\/\/doi.org\/10.1016\/j.cellsig.2009.07.019","journal-title":"Cellular Signalling"},{"issue":"9","key":"9829_CR108","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.febslet.2014.03.015","volume":"588","author":"Eashita Das","year":"2014","unstructured":"Das, E., & Bhattacharyya, N. P. (2014). MicroRNA-432 contributes to dopamine cocktail and retinoic acid induced differentiation of human neuroblastoma cells by targeting NESTIN and RCOR1 genes, 588(9). https:\/\/doi.org\/10.1016\/j.febslet.2014.03.015","journal-title":"FEBS Letters"},{"issue":"3","key":"9829_CR109","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/gtc.12559","volume":"23","author":"Kazunori Watanabe","year":"2018","unstructured":"Watanabe, K., Yamaji, R., & Ohtsuki, T. (2018). MicroRNA-664a-5p promotes neuronal differentiation of SH-SY5Y cells. Genes to cells: devoted to molecular & cellular mechanisms, 23(3), 225\u2013233. https:\/\/doi.org\/10.1111\/gtc.12559","journal-title":"Genes to Cells"},{"key":"9829_CR110","doi-asserted-by":"publisher","unstructured":"Zhao, Z., Ma, X., Hsiao, T.-H., Lin, G., Kosti, A., Yu, X., \u2026 Du, L. (2014). A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation. Oncotarget, 5(9), 2499\u2013512. https:\/\/doi.org\/10.18632\/oncotarget.1703","DOI":"10.18632\/oncotarget.1703"},{"issue":"7","key":"9829_CR111","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/cdd.2010.172","volume":"18","author":"N H Foley","year":"2011","unstructured":"Foley, N. H., Bray, I., Watters, K. M., Das, S., Bryan, K., Bernas, T., \u2026 Stallings, R. L. (2011). MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell death and differentiation, 18(7), 1089\u201398. https:\/\/doi.org\/10.1038\/cdd.2010.172","journal-title":"Cell Death & Differentiation"},{"issue":"4","key":"9829_CR112","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bbrc.2010.03.076","volume":"394","author":"Hailan Chen","year":"2010","unstructured":"Chen, H., Shalom-Feuerstein, R., Riley, J., Zhang, S.-D., Tucci, P., Agostini, M., \u2026 Vasa-Nicotera, M. (2010). miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro, 394(4). https:\/\/doi.org\/10.1016\/j.bbrc.2010.03.076","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"9829_CR113","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrm1703","volume":"6","author":"Sovana Adhikary","year":"2005","unstructured":"Adhikary, S., & Eilers, M. (2005). Transcriptional regulation and transformation by Myc proteins. Nature Reviews Molecular Cell Biology, 6(8), 635\u2013645. https:\/\/doi.org\/10.1038\/nrm1703","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"9","key":"9829_CR114","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/onc.2009.429","volume":"29","author":"P Mestdagh","year":"2009","unstructured":"Mestdagh, P., Fredlund, E., Pattyn, F., Schulte, J. H., Muth, D., Vermeulen, J., \u2026 Vandesompele, J. (2010). MYCN\/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN\/c-MYC-activated tumors. Oncogene, 29(9). https:\/\/doi.org\/10.1038\/onc.2009.429","journal-title":"Oncogene"},{"issue":"2","key":"9829_CR115","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jmb.2004.03.065","volume":"339","author":"Andrea Tanzer","year":"2004","unstructured":"Tanzer, A., & Stadler, P. F. (2004). Molecular evolution of a microRNA cluster. Journal of molecular biology, 339(2), 327\u201335. https:\/\/doi.org\/10.1016\/j.jmb.2004.03.065","journal-title":"Journal of Molecular Biology"},{"key":"9829_CR116","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.biopha.2016.07.010","volume":"83","author":"Zuoqing Li","year":"2016","unstructured":"Li, Z., Xu, Z., Xie, Q., Gao, W., Xie, J., & Zhou, L. (2016). miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3\u03b2 and SFRP1. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 83, 508\u2013513. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.010","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"9829_CR117","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/ddv018","volume":"24","author":"Hongxia Qu","year":"2015","unstructured":"Qu, H., Zheng, L., Pu, J., Mei, H., Xiang, X., Zhao, X., \u2026 Tong, Q. (2015). miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase, 24(9). https:\/\/doi.org\/10.1093\/hmg\/ddv018","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"9829_CR118","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00018-019-03041-4","volume":"76","author":"Aroa Soriano","year":"2019","unstructured":"Soriano, A., Masanas, M., Boloix, A., Masi\u00e1, N., Par\u00eds-Coderch, L., Piskareva, O., \u2026 Segura, M. F. (2019). Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma. Cellular and Molecular Life Sciences, 76(11), 2231\u20132243. https:\/\/doi.org\/10.1007\/s00018-019-03041-4","journal-title":"Cellular and Molecular Life Sciences"},{"key":"9829_CR119","unstructured":"Zhu, K., Su, Y., Xu, B., Wang, Z., Sun, H., Wang, L., \u2026 He, X. (2019). MicroRNA-186-5p represses neuroblastoma cell growth via downregulation of Eg5. American journal of translational research, 11(4), 2245\u20132256. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31105832"},{"issue":"12","key":"9829_CR120","doi-asserted-by":"publisher","first-page":"e0208777","DOI":"10.1371\/journal.pone.0208777","volume":"13","author":"Zhenze Zhao","year":"2018","unstructured":"Zhao, Z., Partridge, V., Sousares, M., Shelton, S. D., Holland, C. L., Pertsemlidis, A., & Du, L. (2018). MicroRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi. PLoS ONE, 13(12). https:\/\/doi.org\/10.1371\/journal.pone.0208777","journal-title":"PLOS ONE"},{"key":"9829_CR121","doi-asserted-by":"publisher","unstructured":"Cao, X. Y., Sun, Z. Y., Zhang, L. J., Chen, M. K., & Yuan, B. (2019). MicroRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7. European Review for Medical and Pharmacological Sciences, 23(2), 716\u2013723. https:\/\/doi.org\/10.26355\/eurrev_201901_16885","DOI":"10.26355\/eurrev_201901_16885"},{"issue":"10","key":"9829_CR122","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/ijc.25436","volume":"127","author":"Johannes H. Schulte","year":"2010","unstructured":"Schulte, J. H., Schowe, B., Mestdagh, P., Kaderali, L., Kalaghatgi, P., Schlierf, S., \u2026 Schramm, A. (2010). Accurate prediction of neuroblastoma outcome based on miRNA expression profiles, 127(10). https:\/\/doi.org\/10.1002\/ijc.25436","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9829_CR123","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1158\/0008-5472.CAN-06-3667","volume":"67","author":"Yongxin Chen","year":"2007","unstructured":"Chen, Y., & Stallings, R. L. (2007). Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis, 67(3). https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3667","journal-title":"Cancer Research"},{"issue":"2","key":"9829_CR124","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20150116","volume":"470","author":"Ling-Ling Zhao","year":"2015","unstructured":"Zhao, L.-L., Jin, F., Ye, X., Zhu, L., Yang, J.-S., & Yang, W.-J. (2015). Expression profiles of miRNAs and involvement of miR-100 and miR-34 in regulation of cell cycle arrest in Artemia. The Biochemical journal, 470(2), 223\u201331. https:\/\/doi.org\/10.1042\/BJ20150116","journal-title":"Biochemical Journal"},{"key":"9829_CR125","doi-asserted-by":"publisher","unstructured":"Stigliani, S., Scaruffi, P., Lagazio, C., Persico, L., Carlini, B., Varesio, L., \u2026 Corrias, M. V. (2015). Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients. Oncotarget, 6(15), 13295\u2013308. https:\/\/doi.org\/10.18632\/oncotarget.3745","DOI":"10.18632\/oncotarget.3745"},{"issue":"5","key":"9829_CR126","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3892\/or.2016.4676","volume":"35","author":"ENRICA FABBRI","year":"2016","unstructured":"Fabbri, E., Montagner, G., Bianchi, N., Finotti, A., Borgatti, M., Lampronti, I., \u2026 Gambari, R. (2016). MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells. Oncology reports, 35(5), 2866\u201372. https:\/\/doi.org\/10.3892\/or.2016.4676","journal-title":"Oncology Reports"},{"key":"9829_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.03.017","volume":"1454","author":"Mrinmay Chakrabarti","year":"2012","unstructured":"Chakrabarti, M., Khandkar, M., Banik, N. L., & Ray, S. K. (2012). Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells, 1454, 1\u201313. https:\/\/doi.org\/10.1016\/j.brainres.2012.03.017","journal-title":"Brain Research"},{"issue":"2","key":"9829_CR128","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11064-012-0936-5","volume":"38","author":"Mrinmay Chakrabarti","year":"2012","unstructured":"Chakrabarti, M., Ai, W., Banik, N. L., & Ray, S. K. (2013). Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells. Neurochemical research, 38(2), 420\u201332. https:\/\/doi.org\/10.1007\/s11064-012-0936-5","journal-title":"Neurochemical Research"},{"key":"9829_CR129","doi-asserted-by":"crossref","unstructured":"Breslow, N., Olshan, A., Beckwith, J. B., & Green, D. M. (1993). Epidemiology of Wilms tumor. Medical and pediatric oncology, 21(3), 172\u201381. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7680412","DOI":"10.1002\/mpo.2950210305"},{"issue":"10","key":"9829_CR130","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1200\/JCO.1994.12.10.2126","volume":"12","author":"D M Green","year":"1994","unstructured":"Green, D. M., Beckwith, J. B., Breslow, N. E., Faria, P., Moksness, J., Finklestein, J. Z., \u2026 Shochat, S. (1994). Treatment of children with stages II to IV anaplastic Wilms\u2019 tumor: a report from the National Wilms\u2019 Tumor Study Group., 12(10). https:\/\/doi.org\/10.1200\/JCO.1994.12.10.2126","journal-title":"Journal of Clinical Oncology"},{"key":"9829_CR131","unstructured":"Malkin, D., Sexsmith, E., Yeger, H., Williams, B. R., & Coppes, M. J. (1994). Mutations of the p53 tumor suppressor gene occur infrequently in Wilms\u2019 tumor. Cancer research, 54(8), 2077\u20139. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8174107"},{"issue":"4","key":"9829_CR132","doi-asserted-by":"publisher","first-page":"e18941","DOI":"10.1371\/journal.pone.0018941","volume":"6","author":"Lesleyann Hawthorn","year":"2011","unstructured":"Hawthorn, L., & Cowell, J. K. (2011). Analysis of Wilms tumors using SNP mapping array-based comparative genomic hybridization, 6(4), e18941. https:\/\/doi.org\/10.1371\/journal.pone.0018941","journal-title":"PLoS ONE"},{"issue":"5827","key":"9829_CR133","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science\/1141515","volume":"316","author":"M. B. Major","year":"2007","unstructured":"Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., \u2026 Moon, R. T. (2007). Wilms tumor suppressor WTX negatively regulates WNT\/beta-catenin signaling. Science (New York, N.Y.), 316(5827), 1043\u20136. https:\/\/doi.org\/10.1126\/science\/1141515","journal-title":"Science"},{"issue":"11","key":"9829_CR134","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1158\/0008-5472.CAN-08-0592","volume":"68","author":"E. J. Kort","year":"2008","unstructured":"Kort, E. J., Farber, L., Tretiakova, M., Petillo, D., Furge, K. A., Yang, X. J., \u2026 Teh, B. T. (2008). The E2F3-oncomir-1 axis is activated in Wilms\u2019 tumor, 68(11). https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0592","journal-title":"Cancer Research"},{"issue":"21","key":"9829_CR135","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Yoji Hayashita","year":"2005","unstructured":"Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., \u2026 Takahashi, T. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, 65(21). https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2352","journal-title":"Cancer Research"},{"issue":"2","key":"9829_CR136","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"Hua Yu","year":"2004","unstructured":"Yu, H., & Jove, R. (2004). The STATs of cancer \u2014 new molecular targets come of age. Nature Reviews Cancer, 4(2), 97\u2013105. https:\/\/doi.org\/10.1038\/nrc1275","journal-title":"Nature Reviews Cancer"},{"issue":"8","key":"9829_CR137","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1158\/0008-5472.CAN-09-4456","volume":"70","author":"A. Veronese","year":"2010","unstructured":"Veronese, A., Lupini, L., Consiglio, J., Visone, R., Ferracin, M., Fornari, F., \u2026 Negrini, M. (2010). Oncogenic role of miR-483-3p at the IGF2\/483 locus, 70(8). https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4456","journal-title":"Cancer Research"},{"issue":"1","key":"9829_CR138","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3892\/mmr.2017.6561","volume":"16","author":"Liyi Hong","year":"2017","unstructured":"Hong, L., Zhao, X., Shao, X., & Zhu, H. (2017). miR-590 regulates WT1 during proliferation of G401 cells. Molecular medicine reports, 16(1), 247\u2013253. https:\/\/doi.org\/10.3892\/mmr.2017.6561","journal-title":"Molecular Medicine Reports"},{"issue":"8","key":"9829_CR139","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jpedsurg.2016.12.005","volume":"52","author":"Mingyu Cui","year":"2017","unstructured":"Cui, M., Liu, W., Zhang, L., Guo, F., Liu, Y., Chen, F., \u2026 Wu, R. (2017). Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms\u2019 tumor. Journal of pediatric surgery, 52(8), 1348\u20131354. https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.12.005","journal-title":"Journal of Pediatric Surgery"},{"issue":"1","key":"9829_CR140","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1620\/tjem.242.43","volume":"242","author":"Mingyu Cui","year":"2017","unstructured":"Cui, M., Liu, W., Zhang, L., Guo, F., Liu, Y., Chen, F., \u2026 Wu, R. (2017). Over-expression of miR-21 and lower PTEN levels in Wilms\u2019 tumor with aggressive behavior. The Tohoku journal of experimental medicine, 242(1), 43\u201352. https:\/\/doi.org\/10.1620\/tjem.242.43","journal-title":"The Tohoku Journal of Experimental Medicine"},{"issue":"10","key":"9829_CR141","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1002\/jcb.25999","volume":"118","author":"Ge-Liang Liu","year":"2017","unstructured":"Liu, G.-L., Yang, H.-J., Liu, B., & Liu, T. (2017). Effects of microRNA-19b on the proliferation, apoptosis, and migration of Wilms\u2019 tumor cells via the PTEN\/PI3K\/AKT signaling pathway. Journal of cellular biochemistry, 118(10), 3424\u20133434. https:\/\/doi.org\/10.1002\/jcb.25999","journal-title":"Journal of Cellular Biochemistry"},{"key":"9829_CR142","doi-asserted-by":"publisher","unstructured":"Zhang, C., Lv, G. Q., Cui, L. F., Guo, C. C., & Liu, Q. E. (2019). MicroRNA-572 targets CDH1 to promote metastasis of Wilms\u2019 tumor. European Review for Medical and Pharmacological Sciences, 23(9), 3709\u20133717. https:\/\/doi.org\/10.26355\/eurrev_201905_17794","DOI":"10.26355\/eurrev_201905_17794"},{"key":"9829_CR143","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.12659\/msm.916230","volume":"25","author":"Yihang Gong","year":"2019","unstructured":"Gong, Y., Zou, B., Chen, J., Ding, L., Li, P., Chen, J., \u2026 Li, J. (2019). Potential five-microRNA signature model for the prediction of prognosis in patients with Wilms tumor. Medical Science Monitor, 25, 5435\u20135444. https:\/\/doi.org\/10.12659\/msm.916230","journal-title":"Medical Science Monitor"},{"key":"9829_CR144","unstructured":"Wang, H.-F., Zhang, Y.-Y., Zhuang, H.-W., & Xu, M. (2017). MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms\u2019 tumor via targeting FRS2. European review for medical and pharmacological sciences, 21(15), 3360\u20133369. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28829507"},{"key":"9829_CR145","doi-asserted-by":"publisher","unstructured":"Liu, Z., He, F., Ouyang, S., Li, Y., Ma, F., Chang, H., \u2026 Wu, J. (2019). MiR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI\/SMAD2\/3 and IGF-1R\/AKT signaling pathways in Wilms\u2019 tumor. BMC Cancer, 19(1). https:\/\/doi.org\/10.1186\/s12885-019-5609-1","DOI":"10.1186\/s12885-019-5609-1"},{"issue":"35","key":"9829_CR146","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1038\/onc.2010.233","volume":"29","author":"J S Imam","year":"2010","unstructured":"Imam, J. S., Buddavarapu, K., Lee-Chang, J. S., Ganapathy, S., Camosy, C., Chen, Y., & Rao, M. K. (2010). MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene, 29(35), 4971\u20139. https:\/\/doi.org\/10.1038\/onc.2010.233","journal-title":"Oncogene"},{"issue":"8","key":"9829_CR147","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1261\/rna.1155108","volume":"14","author":"M. A. Newman","year":"2008","unstructured":"Newman, M. A., Thomson, J. M., & Hammond, S. M. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA (New York, N.Y.), 14(8), 1539\u201349. https:\/\/doi.org\/10.1261\/rna.1155108","journal-title":"RNA"},{"key":"9829_CR148","doi-asserted-by":"publisher","unstructured":"Rakheja, D., Chen, K. S., Liu, Y., Shukla, A. A., Schmid, V., Chang, T.-C., \u2026 Amatruda, J. F. (2014). Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours, (1), 4802. https:\/\/doi.org\/10.1038\/ncomms5802","DOI":"10.1038\/ncomms5802"},{"issue":"7","key":"9829_CR149","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ng.392","volume":"41","author":"Srinivas R Viswanathan","year":"2009","unstructured":"Viswanathan, S. R., Powers, J. T., Einhorn, W., Hoshida, Y., Ng, T. L., Toffanin, S., \u2026 Daley, G. Q. (2009). Lin28 promotes transformation and is associated with advanced human malignancies. Nature genetics, 41(7), 843\u20138. https:\/\/doi.org\/10.1038\/ng.392","journal-title":"Nature Genetics"},{"issue":"9","key":"9829_CR150","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1101\/gad.237149.113","volume":"28","author":"A. Urbach","year":"2014","unstructured":"Urbach, A., Yermalovich, A., Zhang, J., Spina, C. S., Zhu, H., Perez-Atayde, A. R., \u2026 Daley, G. Q. (2014). Lin28 sustains early renal progenitors and induces Wilms tumor. Genes & Development, 28(9), 971\u2013982. https:\/\/doi.org\/10.1101\/gad.237149.113","journal-title":"Genes & Development"},{"issue":"8","key":"9829_CR151","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/gcc.22066","volume":"52","author":"Karin Koller","year":"2013","unstructured":"Koller, K., Das, S., Leuschner, I., Korbelius, M., Hoefler, G., & Guertl, B. (2013). Identification of the transcription factor HOXB4 as a novel target of miR-23a. Genes, chromosomes & cancer, 52(8), 709\u201315. https:\/\/doi.org\/10.1002\/gcc.22066","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"3","key":"9829_CR152","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2350\/13-01-1288-OA.1","volume":"17","author":"Karin Koller","year":"2014","unstructured":"Koller, K., Pichler, M., Koch, K., Zandl, M., Stiegelbauer, V., Leuschner, I., \u2026 Guertl, B. (2014). Nephroblastomas show low expression of microR-204 and high expression of its target, the oncogenic transcription factor MEIS1. Pediatric and developmental pathology: the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 17(3), 169\u201375. https:\/\/doi.org\/10.2350\/13-01-1288-OA.1","journal-title":"Pediatric and Developmental Pathology"},{"key":"9829_CR153","doi-asserted-by":"publisher","unstructured":"Jiang, X., & Li, H. (2018). MiR-1180-5p regulates apoptosis of Wilms\u2019 tumor by targeting<em> p<\/em>73. OncoTargets and Therapy, Volume 11, 823\u2013831. https:\/\/doi.org\/10.2147\/OTT.S148684","DOI":"10.2147\/OTT.S148684"},{"issue":"5","key":"9829_CR154","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/carcin\/bgs126","volume":"33","author":"U. Senanayake","year":"2012","unstructured":"Senanayake, U., Das, S., Vesely, P., Alzoughbi, W., Frohlich, L. F., Chowdhury, P., \u2026 Guertl, B. (2012). miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis, 33(5), 1014\u20131021. https:\/\/doi.org\/10.1093\/carcin\/bgs126","journal-title":"Carcinogenesis"},{"key":"9829_CR155","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.12659\/MSM.913005","volume":"25","author":"Kai Liu","year":"2019","unstructured":"Liu, K., He, B., Xu, J., Li, Y., Guo, C., Cai, Q., & Wang, S. (2019). MiR-483-5p targets MKNK1 to suppress Wilms\u2019 tumor cell proliferation and apoptosis in vitro and in vivo. Medical Science Monitor, 25, 1459\u20131468. https:\/\/doi.org\/10.12659\/MSM.913005","journal-title":"Medical Science Monitor"},{"issue":"12","key":"9829_CR156","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1158\/1535-7163.MCT-10-0397","volume":"9","author":"K. E. Allen","year":"2010","unstructured":"Allen, K. E., & Weiss, G. J. (2010). Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics, 9(12). https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0397","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"9829_CR157","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/1471-2164-13-379","volume":"13","author":"Jana Schmitt","year":"2012","unstructured":"Schmitt, J., Backes, C., Nourkami-Tutdibi, N., Leidinger, P., Deutscher, S., Beier, M., \u2026 Meese, E. (2012). Treatment-independent miRNA signature in blood of wilms tumor patients, 13(1), 379. https:\/\/doi.org\/10.1186\/1471-2164-13-379","journal-title":"BMC Genomics"},{"issue":"1","key":"9829_CR158","doi-asserted-by":"publisher","first-page":"e53417","DOI":"10.1371\/journal.pone.0053417","volume":"8","author":"Jenny A. Watson","year":"2013","unstructured":"Watson, J. A., Bryan, K., Williams, R., Popov, S., Vujanic, G., Coulomb, A., \u2026 O\u2019Sullivan, M. (2013). miRNA profiles as a predictor of chemoresponsiveness in Wilms\u2019 tumor blastema. PLoS ONE, 8(1), e53417. https:\/\/doi.org\/10.1371\/journal.pone.0053417","journal-title":"PLoS ONE"},{"key":"9829_CR159","doi-asserted-by":"publisher","unstructured":"Torrezan, G. T., Ferreira, E. N., Nakahata, A. M., Barros, B. D. F., Castro, M. T. M., Correa, B. R., \u2026 Carraro, D. M. (2014). Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour, 5(1), 4039. https:\/\/doi.org\/10.1038\/ncomms5039","DOI":"10.1038\/ncomms5039"},{"issue":"2","key":"9829_CR160","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ccell.2015.01.002","volume":"27","author":"Jenny Wegert","year":"2015","unstructured":"Wegert, J., Ishaque, N., Vardapour, R., Ge\u00f6rg, C., Gu, Z., Bieg, M., \u2026 Gessler, M. (2015). Mutations in the SIX1\/2 pathway and the DROSHA\/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer cell, 27(2), 298\u2013311. https:\/\/doi.org\/10.1016\/j.ccell.2015.01.002","journal-title":"Cancer Cell"},{"key":"9829_CR161","doi-asserted-by":"publisher","unstructured":"Spreafico, F., Ciceri, S., Gamba, B., Torri, F., Terenziani, M., Collini, P., \u2026 Perotti, D. (2016). Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences. Oncotarget, 7(8), 8908\u201315. https:\/\/doi.org\/10.18632\/oncotarget.6950","DOI":"10.18632\/oncotarget.6950"},{"issue":"3","key":"9829_CR162","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"Alfred King-yin Lam","year":"2017","unstructured":"Lam, A. K.-Y. (2017). Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours, 28(3), 213\u2013227. https:\/\/doi.org\/10.1007\/s12022-017-9484-5","journal-title":"Endocrine Pathology"},{"issue":"3","key":"9829_CR163","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4103\/0019-509X.176749","volume":"52","author":"S Khanna","year":"2015","unstructured":"Khanna, S., Priya, R., Bhartiya, S. K., Basu, S., & Shukla, V. K. (2015). Adrenal tumors: an experience of 10 years in a single surgical unit, 52(3). https:\/\/doi.org\/10.4103\/0019-509X.176749","journal-title":"Indian Journal of Cancer"},{"issue":"3","key":"9829_CR164","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00018-014-1752-7","volume":"72","author":"Peter Igaz","year":"2014","unstructured":"Igaz, P., Igaz, I., Nagy, Z., Ny\u00edr\u0151, G., Szab\u00f3, P. M., Falus, A., \u2026 R\u00e1cz, K. (2015). MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy. Cellular and Molecular Life Sciences, 72(3), 417\u2013428. https:\/\/doi.org\/10.1007\/s00018-014-1752-7","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"7","key":"9829_CR165","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/PAI.0000000000000117","volume":"23","author":"Meora Feinmesser","year":"2015","unstructured":"Feinmesser, M., Benbassat, C., Meiri, E., Benjamin, H., Lebanony, D., Lebenthal, Y., \u2026 Spector, Y. (2015). Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system. Applied Immunohistochemistry & Molecular Morphology, 23(7), 522\u2013531. https:\/\/doi.org\/10.1097\/PAI.0000000000000117","journal-title":"Applied Immunohistochemistry & Molecular Morphology"},{"issue":"6","key":"9829_CR166","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2265.2009.03725.x","volume":"72","author":"Eirini I. Bimpaki","year":"2009","unstructured":"Bimpaki, E. I., Iliopoulos, D., Moraitis, A., & Stratakis, C. A. (2009). MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis. Clinical Endocrinology, 72(6), 744\u2013751. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03725.x","journal-title":"Clinical Endocrinology"},{"key":"9829_CR167","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7150\/jgen.22060","volume":"5","author":"Srinivas V. Koduru","year":"2017","unstructured":"Koduru, S. V., Leberfinger, A. N., & Ravnic, D. J. (2017). Small non-coding RNA abundance in adrenocortical carcinoma: a footprint of a rare cancer. Journal of Genomics, 5, 99\u2013118. https:\/\/doi.org\/10.7150\/jgen.22060","journal-title":"Journal of Genomics"},{"issue":"4","key":"9829_CR168","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ijc.31363","volume":"143","author":"Claire Agosta","year":"2018","unstructured":"Agosta, C., Laugier, J., Guyon, L., Denis, J., Bertherat, J., Lib\u00e9, R., \u2026 Cherradi, N. (2018). MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer. International Journal of Cancer, 143(4), 944\u2013957. https:\/\/doi.org\/10.1002\/ijc.31363","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9829_CR169","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","volume":"62","author":"Stacy Robertson","year":"2013","unstructured":"Robertson, S., MacKenzie, S. M., Alvarez-Madrazo, S., Diver, L. A., Lin, J., Stewart, P. M., \u2026 Davies, E. (2013). MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex. Hypertension, 62(3), 572\u2013578. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01102","journal-title":"Hypertension"},{"key":"9829_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2021903","volume":"2017","author":"Stacy Robertson","year":"2017","unstructured":"Robertson, S., Diver, L. A., Alvarez-Madrazo, S., Livie, C., Ejaz, A., Fraser, R., \u2026 Davies, E. (2017). Regulation of corticosteroidogenic genes by microRNAs, 2017. https:\/\/doi.org\/10.1155\/2017\/2021903","journal-title":"International Journal of Endocrinology"},{"issue":"2","key":"9829_CR171","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.marpolbul.2014.04.002","volume":"85","author":"Suraia Nusrin","year":"2014","unstructured":"Nusrin, S., Tong, S. K. H. H., Chaturvedi, G., Wu, R. S. S. S., Giesy, J. P., & Kong, R. Y. C. C. (2014). Regulation of CYP11B1 and CYP11B2 steroidogenic genes by hypoxia-inducible miR-10b in H295R cells, 85(2). https:\/\/doi.org\/10.1016\/j.marpolbul.2014.04.002","journal-title":"Marine Pollution Bulletin"},{"issue":"6","key":"9829_CR172","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1634\/theoncologist.2018-0849","volume":"24","author":"Grace T.Y. Kwok","year":"2019","unstructured":"Kwok, G. T. Y., Zhao, J. T., Glover, A. R., Gill, A. J., Clifton-Bligh, R., Robinson, B. G., \u2026 Sidhu, S. B. (2019). microRNA-431 as a chemosensitizer and potentiator of drug activity in adrenocortical carcinoma. The Oncologist, 24(6), e241\u2013e250. https:\/\/doi.org\/10.1634\/theoncologist.2018-0849","journal-title":"The Oncologist"},{"issue":"1-2","key":"9829_CR173","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mce.2010.11.008","volume":"336","author":"Abeer El Wakil","year":"2011","unstructured":"El Wakil, A., Doghman, M., Latre De Late, P., Zambetti, G. P., Figueiredo, B. C., & Lalli, E. (2011). Genetics and genomics of childhood adrenocortical tumors. Molecular and Cellular Endocrinology, 336(1\u20132), 169\u2013173. https:\/\/doi.org\/10.1016\/j.mce.2010.11.008","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"9829_CR174","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2011.09.040","volume":"351","author":"Andr\u00e9 M. Faria","year":"2012","unstructured":"Faria, A. M., & Almeida, M. Q. (2012). Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Molecular and Cellular Endocrinology, 351(1), 52\u201357. https:\/\/doi.org\/10.1016\/j.mce.2011.09.040","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"11","key":"9829_CR175","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","volume":"70","author":"Mabrouka Doghman","year":"2010","unstructured":"Doghman, M., Wakil, A. El, Cardinaud, B., Thomas, E., Wang, J., Zhao, W., \u2026 Lalli, E. (2010). Regulation of insulin-like growth factor\u2013mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors, 70(11). https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3970","journal-title":"Cancer Research"},{"issue":"9","key":"9829_CR176","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1210\/jc.2008-0065","volume":"93","author":"Madson Q. Almeida","year":"2008","unstructured":"Almeida, M. Q., Fragoso, M. C. B. V., Lotfi, C. F. P., Santos, M. G., Nishi, M. Y., Costa, M. H. S., \u2026 Latronico, A. C. (2008). Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors, 93(9). https:\/\/doi.org\/10.1210\/jc.2008-0065","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9829_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/936031","volume":"2014","author":"Tamaya Castro Ribeiro","year":"2014","unstructured":"Ribeiro, T. C., Jorge, A. A., Almeida, M. Q., Mariani, B. M. de P., Nishi, M. Y., Mendonca, B. B., \u2026 Latronico, A. C. (2014). Amplification of the insulin-like growth factor 1 receptor gene is a rare event in adrenocortical adenocarcinomas: searching for potential mechanisms of overexpression, 2014. https:\/\/doi.org\/10.1155\/2014\/936031","journal-title":"BioMed Research International"},{"key":"9829_CR178","doi-asserted-by":"publisher","unstructured":"Finegold, M. J., Lopez-Terrada, D. H., Bowen, J., Washington, M. K., Qualman, S. J., & College of American Pathologists. (2007). Protocol for the examination of specimens from pediatric patients with hepatoblastoma. Archives of pathology & laboratory medicine, 131(4), 520\u20139. https:\/\/doi.org\/10.1043\/1543-2165(2007)131[520:PFTEOS]2.0.CO;2","DOI":"10.1043\/1543-2165(2007)131[520:PFTEOS]2.0.CO;2"},{"issue":"5","key":"9829_CR179","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.24215","volume":"59","author":"Logan G. Spector","year":"2012","unstructured":"Spector, L. G., & Birch, J. (2012). The epidemiology of hepatoblastoma. Pediatric blood & cancer, 59(5), 776\u20139. https:\/\/doi.org\/10.1002\/pbc.24215","journal-title":"Pediatric Blood & Cancer"},{"issue":"12","key":"9829_CR180","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.ejca.2011.10.019","volume":"48","author":"Rachel Purcell","year":"2012","unstructured":"Purcell, R., Childs, M., Maibach, R., Miles, C., Turner, C., Zimmermann, A., \u2026 Sullivan, M. (2012). Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study. European journal of cancer (Oxford, England: 1990), 48(12), 1853\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2011.10.019","journal-title":"European Journal of Cancer"},{"issue":"6","key":"9829_CR181","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/pbc.24428","volume":"60","author":"Carlos Rodriguez-Galindo","year":"2012","unstructured":"Rodriguez-Galindo, C., Krailo, M., Frazier, L., Chintagumpala, M., Amatruda, J., Katzenstein, H., \u2026 COG Rare Tumors Disease Committee. (2013). Children\u2019s Oncology Group\u2019s 2013 blueprint for research: rare tumors. Pediatric blood & cancer, 60(6), 1016\u201321. https:\/\/doi.org\/10.1002\/pbc.24428","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"9829_CR182","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cncr.23169","volume":"112","author":"Amy M. Linabery","year":"2008","unstructured":"Linabery, A. M., & Ross, J. A. (2008). Trends in childhood cancer incidence in the U.S. (1992\u20132004). Cancer, 112(2), 416\u201332. https:\/\/doi.org\/10.1002\/cncr.23169","journal-title":"Cancer"},{"key":"9829_CR183","unstructured":"Anna, C. H., Sills, R. C., Foley, J. F., Stockton, P. S., Ton, T.-V., & Devereux, T. R. (2000). Catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. CANCER RESEARCH (Vol. 60). Retrieved from http:\/\/cancerres.aacrjournals.org\/content\/canres\/60\/11\/2864.full.pdf"},{"issue":"2","key":"9829_CR184","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biocel.2009.07.012","volume":"43","author":"C. Armengol","year":"2011","unstructured":"Armengol, C., Cairo, S., Fabre, M., & Buendia, M. A. (2011). Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. The international journal of biochemistry & cell biology, 43(2), 265\u201370. https:\/\/doi.org\/10.1016\/j.biocel.2009.07.012","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"9829_CR185","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","volume":"26","author":"Piotr Czauderna","year":"2014","unstructured":"Czauderna, P., Lopez-Terrada, D., Hiyama, E., H\u00e4berle, B., Malogolowkin, M. H., & Meyers, R. L. (2014). Hepatoblastoma state of the art. Current Opinion in Pediatrics, 26(1), 19\u201328. https:\/\/doi.org\/10.1097\/MOP.0000000000000046","journal-title":"Current Opinion in Pediatrics"},{"issue":"3","key":"9829_CR186","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"27","author":"Dolores L\u00f3pez-Terrada","year":"2013","unstructured":"L\u00f3pez-Terrada, D., Alaggio, R., de D\u00e1vila, M. T., Czauderna, P., Hiyama, E., Katzenstein, H., \u2026 Children\u2019s Oncology Group Liver Tumor Committee. (2014). Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 27(3), 472\u201391. https:\/\/doi.org\/10.1038\/modpathol.2013.80","journal-title":"Modern Pathology"},{"issue":"10","key":"9829_CR187","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","volume":"48","author":"Rudolf Maibach","year":"2012","unstructured":"Maibach, R., Roebuck, D., Brugieres, L., Capra, M., Brock, P., Dall\u2019Igna, P., \u2026 Perilongo, G. (2012). Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. European journal of cancer (Oxford, England: 1990), 48(10), 1543\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2011.12.011","journal-title":"European Journal of Cancer"},{"issue":"3","key":"9829_CR188","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","volume":"38","author":"A Darbari","year":"2003","unstructured":"Darbari, A., Sabin, K. M., Shapiro, C. N., & Schwarz, K. B. (2003). Epidemiology of primary hepatic malignancies in U.S. children. https:\/\/doi.org\/10.1053\/jhep.2003.50375","journal-title":"Hepatology"},{"issue":"4","key":"9829_CR189","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.canep.2013.03.004","volume":"37","author":"Julia E. Heck","year":"2013","unstructured":"Heck, J. E., Meyers, T. J., Lombardi, C., Park, A. S., Cockburn, M., Reynolds, P., & Ritz, B. (2013). Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer epidemiology, 37(4), 390\u20135. https:\/\/doi.org\/10.1016\/j.canep.2013.03.004","journal-title":"Cancer Epidemiology"},{"key":"9829_CR190","unstructured":"Ries, L., Harkins, D., Krapcho, M., Mariotto, A., Miller, B., Feuer, E., \u2026 Edwards, B. (2006). SEER Cancer Statistics Review, 1975\u20132003. Public Health Faculty Publications. Retrieved from https:\/\/scholarworks.gsu.edu\/iph_facpub\/132"},{"issue":"6","key":"9829_CR191","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ajmg.1320430621","volume":"43","author":"Linda J. Hughes","year":"1992","unstructured":"Hughes, L. J., & Michels, V. V. (1992). Risk of hepatoblastoma in familial adenomatous polyposis. American Journal of Medical Genetics, 43(6), 1023\u20131025. https:\/\/doi.org\/10.1002\/ajmg.1320430621","journal-title":"American Journal of Medical Genetics"},{"issue":"10","key":"9829_CR192","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/1055-9965.EPI-13-0432","volume":"22","author":"K. J. Johnson","year":"2013","unstructured":"Johnson, K. J., Williams, K. S., Ross, J. A., Krailo, M. D., Tomlinson, G. E., Malogolowkin, M. H., \u2026 Spector, L. G. (2013). Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the Children\u2019s Oncology Group. Cancer Epidemiology Biomarkers & Prevention, 22(10), 1837\u20131843. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0432","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"3","key":"9829_CR193","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0022-3476(98)70008-3","volume":"132","author":"Michael R. DeBaun","year":"1998","unstructured":"DeBaun, M. R., & Tucker, M. A. (1998). Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. The Journal of Pediatrics, 132(3), 398\u2013400. https:\/\/doi.org\/10.1016\/S0022-3476(98)70008-3","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"9829_CR194","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ejca.2004.10.024","volume":"41","author":"P. Ansell","year":"2005","unstructured":"Ansell, P., Mitchell, C. D., Roman, E., Simpson, J., Birch, J. M., & Eden, T. O. B. (2005). Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. European journal of cancer (Oxford, England: 1990), 41(5), 741\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2004.10.024","journal-title":"European Journal of Cancer"},{"issue":"19","key":"9829_CR195","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMoa1301675","volume":"369","author":"Carrie L. Williams","year":"2013","unstructured":"Williams, C. L., Bunch, K. J., Stiller, C. A., Murphy, M. F. G., Botting, B. J., Wallace, W. H., \u2026 Sutcliffe, A. G. (2013). Cancer risk among children born after assisted conception. New England Journal of Medicine, 369(19), 1819\u20131827. https:\/\/doi.org\/10.1056\/NEJMoa1301675","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"9829_CR196","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","volume":"18","author":"Jorge A. Ortega","year":"2000","unstructured":"Ortega, J. A., Douglass, E. C., Feusner, J. H., Reynolds, M., Quinn, J. J., Finegold, M. J., \u2026 Krailo, M. D. (2000). Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 18(14), 2665\u201375. https:\/\/doi.org\/10.1200\/JCO.2000.18.14.2665","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"9829_CR197","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MOP.0000000000000081","volume":"26","author":"Nathalie Kremer","year":"2014","unstructured":"Kremer, N., Walther, A. E., & Tiao, G. M. (2014). Management of hepatoblastoma. Current Opinion in Pediatrics, 26(3), 362\u2013369. https:\/\/doi.org\/10.1097\/MOP.0000000000000081","journal-title":"Current Opinion in Pediatrics"},{"key":"9829_CR198","doi-asserted-by":"publisher","first-page":"53","DOI":"10.12688\/f1000research.12239.1","volume":"7","author":"Piotr Czauderna","year":"2018","unstructured":"Czauderna, P., & Garnier, H. (2018). Hepatoblastoma: current understanding, recent advances, and controversies. F1000Research, 7, 53. https:\/\/doi.org\/10.12688\/f1000research.12239.1","journal-title":"F1000Research"},{"key":"9829_CR199","doi-asserted-by":"crossref","unstructured":"Haeberle, B., & Schweinitz, D. von. (2012). Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Frontiers in bioscience (Elite edition), 4, 493\u20138. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22201890","DOI":"10.2741\/e395"},{"issue":"3","key":"9829_CR200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1593\/tlo.09124","volume":"2","author":"Armando Magrelli","year":"2009","unstructured":"Magrelli, A., Azzalin, G., Salvatore, M., Viganotti, M., Tosto, F., Colombo, T., \u2026 Taruscio, D. (2009). Altered microRNA expression patterns in hepatoblastoma patients. Translational oncology, 2(3), 157\u201363. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19701500","journal-title":"Translational Oncology"},{"issue":"47","key":"9829_CR201","doi-asserted-by":"publisher","first-page":"20471","DOI":"10.1073\/pnas.1009009107","volume":"107","author":"S. Cairo","year":"2010","unstructured":"Cairo, S., Wang, Y., de Reynies, A., Duroure, K., Dahan, J., Redon, M.-J., \u2026 Buendia, M.-A. (2010). Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proceedings of the National Academy of Sciences, 107(47), 20471\u201320476. https:\/\/doi.org\/10.1073\/pnas.1009009107","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"9829_CR202","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3892\/ol.2016.5196","volume":"12","author":"Jimin He","year":"2016","unstructured":"He, J., Guo, X., Sun, L., Wang, N., & Bao, J. (2016). Regulatory network analysis of genes and microRNAs in human hepatoblastoma. Oncology Letters, 12(5), 4099\u20134106. https:\/\/doi.org\/10.3892\/ol.2016.5196","journal-title":"Oncology Letters"},{"issue":"3","key":"9829_CR203","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.24125","volume":"53","author":"Julia von Frowein","year":"2011","unstructured":"von Frowein, J., Pagel, P., Kappler, R., von Schweinitz, D., Roscher, A., & Schmid, I. (2011). MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology, 53(3), 833\u2013842. https:\/\/doi.org\/10.1002\/hep.24125","journal-title":"Hepatology"},{"issue":"7","key":"9829_CR204","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/liv.13687","volume":"38","author":"Julia von Frowein","year":"2018","unstructured":"von Frowein, J., Hauck, S. M., Kappler, R., Pagel, P., Fleischmann, K. K., Magg, T., \u2026 Schmid, I. (2018). MiR-492 regulates metastatic properties of hepatoblastoma via CD44. Liver International, 38(7), 1280\u20131291. https:\/\/doi.org\/10.1111\/liv.13687","journal-title":"Liver International"},{"issue":"2","key":"9829_CR205","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hep4.1029","volume":"1","author":"Emilie Indersie","year":"2017","unstructured":"Indersie, E., Lesjean, S., Hooks, K. B., Sagliocco, F., Ernault, T., Cairo, S., \u2026 Grosset, C. F. (2017). MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting \u03b2-catenin and Wnt signaling. Hepatology communications, 1(2), 168\u2013183. https:\/\/doi.org\/10.1002\/hep4.1029","journal-title":"Hepatology Communications"},{"issue":"1","key":"9829_CR206","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MPH.0000000000001234","volume":"41","author":"\u00c7i\u011fdem \u00d6. Ecevit","year":"2019","unstructured":"Ecevit, \u00c7. O., Akta\u015f, S., Tosun Yildirim, H., Demira\u01e7, B., Erbay, A., Karaca, I., \u2026 Olgun, N. (2019). MicroRNA-17, microRNA-19b, microRNA-146a, microRNA-302d expressions in hepatoblastoma and clinical importance. Journal of Pediatric Hematology\/Oncology, 41(1), 7\u201312. https:\/\/doi.org\/10.1097\/MPH.0000000000001234","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"4","key":"9829_CR207","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00428-014-1549-y","volume":"464","author":"M\u00f3nika Gyugos","year":"2014","unstructured":"Gyugos, M., Lendvai, G., Kenessey, I., Schlachter, K., Hal\u00e1sz, J., Nagy, P., \u2026 Kiss, A. (2014). MicroRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Archiv: an international journal of pathology, 464(4), 419\u201327. https:\/\/doi.org\/10.1007\/s00428-014-1549-y","journal-title":"Virchows Archiv"},{"issue":"8","key":"9829_CR208","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jpedsurg.2016.02.091","volume":"51","author":"Chenwei Jiao","year":"2016","unstructured":"Jiao, C., Zhu, A., Jiao, X., Ge, J., & Xu, X. (2016). Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: a Chinese population-based study. Journal of pediatric surgery, 51(8), 1355\u201361. https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.02.091","journal-title":"Journal of Pediatric Surgery"},{"key":"9829_CR209","doi-asserted-by":"publisher","unstructured":"Liu, S., Xie, F., Xiang, X., Liu, S., Dong, S., Qu, K., & Lin, T. (2017). Identification of differentially expressed genes, lncRNAs and miRNAs which are associated with tumor malignant phenotypes in hepatoblastoma patients. Oncotarget, 8(57), 97554\u201397564. https:\/\/doi.org\/10.18632\/oncotarget.22181","DOI":"10.18632\/oncotarget.22181"},{"issue":"2","key":"9829_CR210","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cld.2015.01.010","volume":"19","author":"Deirdre Kelly","year":"2015","unstructured":"Kelly, D., Sharif, K., Brown, R. M., & Morland, B. (2015). Hepatocellular carcinoma in children. Clinics in Liver Disease, 19(2), 433\u2013447. https:\/\/doi.org\/10.1016\/j.cld.2015.01.010","journal-title":"Clinics in Liver Disease"},{"key":"9829_CR211","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JHC.S94008","volume":"Volume 4","author":"Irene Schmid","year":"2017","unstructured":"Schmid, I., & von Schweinitz, D. (2017). Pediatric hepatocellular carcinoma: challenges and solutions. Journal of hepatocellular carcinoma, 4, 15\u201321. https:\/\/doi.org\/10.2147\/JHC.S94008","journal-title":"Journal of Hepatocellular Carcinoma"},{"key":"9829_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6784607","volume":"2018","author":"Erbao Chen","year":"2018","unstructured":"Chen, E., Xu, X., Liu, R., & Liu, T. (2018). Small but heavy role: microRNAs in hepatocellular carcinoma progression. BioMed Research International, 2018, 1\u20139. https:\/\/doi.org\/10.1155\/2018\/6784607","journal-title":"BioMed Research International"},{"key":"9829_CR213","unstructured":"ATCC: The Global Bioresource Center. (n.d.). 2018. Retrieved October 10, 2018, from https:\/\/www.atcc.org\/"},{"issue":"13","key":"9829_CR214","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","volume":"67","author":"L. Gramantieri","year":"2007","unstructured":"Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.-G., \u2026 Negrini, M. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Research, 67(13), 6092\u20136099. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4607","journal-title":"Cancer Research"},{"issue":"3","key":"9829_CR215","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2008.07.154","volume":"375","author":"Cliff Ji-Fan Lin","year":"2008","unstructured":"Lin, C. J.-F., Gong, H.-Y., Tseng, H.-C., Wang, W.-L., & Wu, J.-L. (2008). miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochemical and biophysical research communications, 375(3), 315\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.154","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"9829_CR216","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3892\/or.2015.4175","volume":"34","author":"QIURAN XU","year":"2015","unstructured":"Xu, Q., Zhang, M., Tu, J., Pang, L., Cai, W., & LIU, X. (2015). MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma, 34(4). https:\/\/doi.org\/10.3892\/or.2015.4175","journal-title":"Oncology Reports"},{"issue":"5","key":"9829_CR217","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1478-3231.2011.02750.x","volume":"32","author":"Jie Xu","year":"2012","unstructured":"Xu, J., Zhu, X., Wu, L., Yang, R., Yang, Z., Wang, Q., & Wu, F. (2012). MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt\/\u03b2-catenin pathway, 32(5). https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02750.x","journal-title":"Liver International"},{"issue":"4","key":"9829_CR218","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1535370216681548","volume":"242","author":"Subodh Kumar","year":"2016","unstructured":"Kumar, S., Batra, A., Kanthaje, S., Ghosh, S., & Chakraborti, A. (2017). Crosstalk between microRNA-122 and FOX family genes in HepG2 cells, 242(4), 436\u2013440. https:\/\/doi.org\/10.1177\/1535370216681548","journal-title":"Experimental Biology and Medicine"},{"issue":"5","key":"9829_CR219","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.3892\/mmr.2015.4254","volume":"12","author":"HONGYAN HUANG","year":"2015","unstructured":"Huang, H., Zhu, Y., & Li, S. (2015). MicroRNA-122 mimic transfection contributes to apoptosis in HepG2 cells. Molecular medicine reports, 12(5), 6918\u201324. https:\/\/doi.org\/10.3892\/mmr.2015.4254","journal-title":"Molecular Medicine Reports"},{"key":"9829_CR220","unstructured":"Shu, X.-L., Fan, C.-B., Long, B., Zhou, X., & Wang, Y. (2016). The anti-cancer effects of cisplatin on hepatic cancer are associated with modulation of miRNA-21 and miRNA-122 expression. European review for medical and pharmacological sciences, 20(21), 4459\u20134465. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27874954"},{"issue":"1","key":"9829_CR221","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12291-017-0651-8","volume":"33","author":"Shaymaa M. M. Yahya","year":"2017","unstructured":"Yahya, S. M. M., Fathy, S. A., El-Khayat, Z. A., El-Toukhy, S. E., Hamed, A. R., Hegazy, M. G. A., & Nabih, H. K. (2018). Possible role of microRNA-122 in modulating multidrug resistance of hepatocellular carcinoma. Indian journal of clinical biochemistry: IJCB, 33(1), 21\u201330. https:\/\/doi.org\/10.1007\/s12291-017-0651-8","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"9829_CR222","doi-asserted-by":"publisher","unstructured":"Zeng, X., Yuan, Y., Wang, T., Wang, H., Hu, X., Fu, Z., \u2026 Lu, G. (2017). Targeted imaging and induction of apoptosis of drug-resistant hepatoma cells by miR-122-loaded graphene-InP nanocompounds. Journal of Nanobiotechnology, 15(1), 9. https:\/\/doi.org\/10.1186\/s12951-016-0237-2","DOI":"10.1186\/s12951-016-0237-2"},{"issue":"2","key":"9829_CR223","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/mmr.2012.1233","volume":"7","author":"AIMEI LI","year":"2012","unstructured":"LI, A., QIAN, J., HE, J., ZHANG, Q., ZHAI, A., SONG, W., \u2026 ZHANG, F. (2013). Modulation of miR-122 expression affects the interferon response in human hepatoma cells. Molecular Medicine Reports, 7(2), 585\u2013590. https:\/\/doi.org\/10.3892\/mmr.2012.1233","journal-title":"Molecular Medicine Reports"},{"issue":"11","key":"9829_CR224","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/cgt.2015.51","volume":"22","author":"Z Najafi","year":"2015","unstructured":"Najafi, Z., Sharifi, M., & Javadi, G. (2015). Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma. Cancer gene therapy, 22(11), 530\u20135. https:\/\/doi.org\/10.1038\/cgt.2015.51","journal-title":"Cancer Gene Therapy"},{"issue":"5","key":"9829_CR225","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1541-7786.MCR-09-0465","volume":"8","author":"Erin C. Connolly","year":"2010","unstructured":"Connolly, E. C., Van Doorslaer, K., Rogler, L. E., & Rogler, C. E. (2010). Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Molecular cancer research: MCR, 8(5), 691\u2013700. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0465","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"9829_CR226","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1007\/s13277-015-3213-9","volume":"36","author":"Shuxiang Hu","year":"2015","unstructured":"Hu, S., Tao, R., Wang, S., Wang, C., Zhao, X., Zhao, H., \u2026 Gao, Y. (2015). MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1, 36(7). https:\/\/doi.org\/10.1007\/s13277-015-3213-9","journal-title":"Tumor Biology"},{"issue":"4","key":"9829_CR227","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3892\/or.2016.5026","volume":"36","author":"Dian Yin","year":"2016","unstructured":"Yin, D., Wang, Y., Sai, W., Zhang, L., Miao, Y., Cao, L., \u2026 Yang, L. (2016). HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12. Oncology reports, 36(4), 2305\u201312. https:\/\/doi.org\/10.3892\/or.2016.5026","journal-title":"Oncology Reports"},{"key":"9829_CR228","doi-asserted-by":"publisher","unstructured":"Xu, G., Zhang, Y., Wei, J., Jia, W., Ge, Z., Zhang, Z., & Liu, X. (2013). MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC cancer, 13(1), 469. https:\/\/doi.org\/10.1186\/1471-2407-13-469","DOI":"10.1186\/1471-2407-13-469"},{"key":"9829_CR229","doi-asserted-by":"publisher","unstructured":"Zhu, Q., Wang, Z., Hu, Y., Li, J., Li, X., Zhou, L., & Huang, Y. (2012). miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncology reports, 27(5), 1660\u20138. https:\/\/doi.org\/10.3892\/or.2012.1682","DOI":"10.3892\/or.2012.1682"},{"issue":"10","key":"9829_CR230","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/sj.bjc.6605958","volume":"103","author":"Y Tomimaru","year":"2010","unstructured":"Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Tomokuni, A., Kobayashi, S., \u2026 Mori, M. (2010). MicroRNA-21 induces resistance to the anti-tumour effect of interferon-\u03b1\/5-fluorouracil in hepatocellular carcinoma cells, 103(10). https:\/\/doi.org\/10.1038\/sj.bjc.6605958","journal-title":"British Journal of Cancer"},{"issue":"4","key":"9829_CR231","doi-asserted-by":"publisher","first-page":"e0124266","DOI":"10.1371\/journal.pone.0124266","volume":"10","author":"Xiuming Zhu","year":"2015","unstructured":"Zhu, X., Wu, L., Yao, J., Jiang, H., Wang, Q., Yang, Z., & Wu, F. (2015). MicroRNA let-7c inhibits cell proliferation and induces cell cycle arrest by targeting CDC25A in human hepatocellular carcinoma. PloS one, 10(4), e0124266. https:\/\/doi.org\/10.1371\/journal.pone.0124266","journal-title":"PLOS ONE"},{"issue":"5","key":"9829_CR232","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1007\/s13277-015-4427-6","volume":"37","author":"Jianting Long","year":"2015","unstructured":"Long, J., Jiang, C., Liu, B., Fang, S., & Kuang, M. (2016). MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 37(5), 5821\u20138. https:\/\/doi.org\/10.1007\/s13277-015-4427-6","journal-title":"Tumor Biology"},{"key":"9829_CR233","unstructured":"Wang, Y., Zhao, Y.-R., Zhang, A.-Y., Ma, J., Wang, Z.-Z., & Zhang, X. (2017). Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells. European review for medical and pharmacological sciences, 21(9), 2087\u20132097. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28537677"},{"issue":"1","key":"9829_CR234","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1756-9966-32-21","volume":"32","author":"Ming-Qi Fan","year":"2013","unstructured":"Fan, M.-Q., Huang, C.-B., Gu, Y., Xiao, Y., Sheng, J.-X., & Zhong, L. (2013). Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. Journal of experimental & clinical cancer research: CR, 32(1), 21. https:\/\/doi.org\/10.1186\/1756-9966-32-21","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"7","key":"9829_CR235","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4103\/0366-6999.154302","volume":"128","author":"Shuo Li","year":"2015","unstructured":"Li, S., Li, J., Fei, B.-Y., Shao, D., Pan, Y., Mo, Z.-H., \u2026 Chen, L. (2015). MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor \u03b3. Chinese medical journal, 128(7), 941\u20137. https:\/\/doi.org\/10.4103\/0366-6999.154302","journal-title":"Chinese Medical Journal"},{"key":"9829_CR236","doi-asserted-by":"publisher","unstructured":"Zhao, N., Sun, H., Sun, B., Zhu, D., Zhao, X., Wang, Y., \u2026 Li, X. (2016). miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC, 6(1), 23091. https:\/\/doi.org\/10.1038\/srep23091","DOI":"10.1038\/srep23091"},{"issue":"7","key":"9829_CR237","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/jcb.26526","volume":"119","author":"Jin-Mao Li","year":"2018","unstructured":"Li, J.-M., Zhou, J., Xu, Z., Huang, H.-J., Chen, M.-J., & Ji, J.-S. (2018). MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma, 119(7), 5143\u20135152. https:\/\/doi.org\/10.1002\/jcb.26526","journal-title":"Journal of Cellular Biochemistry"},{"key":"9829_CR238","doi-asserted-by":"crossref","unstructured":"Wu, X.-J., Li, Y., Liu, D., Zhao, L.-D., Bai, B., & Xue, M.-H. (2013). miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma. Asian Pacific journal of cancer prevention: APJCP, 14(2), 885\u20139. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23621256","DOI":"10.7314\/APJCP.2013.14.2.885"},{"issue":"3","key":"9829_CR239","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbrc.2011.06.191","volume":"411","author":"Chun-Mei Wang","year":"2011","unstructured":"Wang, C.-M., Wang, Y., Fan, C.-G., Xu, F.-F., Sun, W.-S., Liu, Y.-G., & Jia, J.-H. (2011). miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochemical and biophysical research communications, 411(3), 586\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2011.06.191","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR240","unstructured":"He, R., Yang, L., Lin, X., Chen, X., Lin, X., Wei, F., \u2026 Chen, G. (2015). MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. International journal of clinical and experimental pathology, 8(12), 15632\u201341. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26884832"},{"issue":"5","key":"9829_CR241","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1007\/s13277-015-4456-1","volume":"37","author":"Wen-fang Li","year":"2015","unstructured":"Li, W.-F., Dai, H., Ou, Q., Zuo, G.-Q., & Liu, C.-A. (2016). Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH\/PTEN\/AKT pathway. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 37(5), 5885\u201395. https:\/\/doi.org\/10.1007\/s13277-015-4456-1","journal-title":"Tumor Biology"},{"key":"9829_CR242","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.biopha.2017.07.029","volume":"93","author":"Kun Zhou","year":"2017","unstructured":"Zhou, K., Luo, X., Wang, Y., Cao, D., & Sun, G. (2017). MicroRNA-30a suppresses tumor progression by blocking Ras\/Raf\/MEK\/ERK signaling pathway in hepatocellular carcinoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 93, 1025\u20131032. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.029","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"9829_CR243","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3727\/096504016X14821952695683","volume":"25","author":"Tinghui Jiang","year":"2017","unstructured":"Jiang, T., Li, M., Li, Q., Guo, Z., Sun, X., Zhang, X., \u2026 Xiao, P. (2017). MicroRNA-98-5p inhibits cell proliferation and induces cell apoptosis in hepatocellular carcinoma via targeting IGF2BP1. Oncology research, 25(7), 1117\u20131127. https:\/\/doi.org\/10.3727\/096504016X14821952695683","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"issue":"2","key":"9829_CR244","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13577-014-0105-z","volume":"28","author":"Chunfang Zhao","year":"2015","unstructured":"Zhao, C., Li, Y., Zhang, M., Yang, Y., & Chang, L. (2015). miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. Human cell, 28(2), 91\u20139. https:\/\/doi.org\/10.1007\/s13577-014-0105-z","journal-title":"Human Cell"},{"issue":"3","key":"9829_CR245","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3892\/or.2015.3734","volume":"33","author":"CHANGLI ZHENG","year":"2015","unstructured":"Zheng, C., Li, J., Wang, Q., Liu, W., Zhou, J., Liu, R., \u2026 Cao, K. (2015). MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma. Oncology reports, 33(3), 1115\u201322. https:\/\/doi.org\/10.3892\/or.2015.3734","journal-title":"Oncology Reports"},{"key":"9829_CR246","doi-asserted-by":"publisher","unstructured":"Lin, L., Liang, H., Wang, Y., Yin, X., Hu, Y., Huang, J., \u2026 Chen, X. (2014). microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3\u03b2 in hepatocellular carcinoma cells. BMC cancer, 14(1), 879. https:\/\/doi.org\/10.1186\/1471-2407-14-879","DOI":"10.1186\/1471-2407-14-879"},{"issue":"6","key":"9829_CR247","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1159\/000374036","volume":"35","author":"Liang Shi","year":"2015","unstructured":"Shi, L., Wu, L., Chen, Z., Yang, J., Chen, X., Yu, F., \u2026 Lin, X. (2015). MiR-141 activates Nrf2-dependent antioxidant pathway via down-regulating the expression of Keap1 conferring the resistance of hepatocellular carcinoma cells to 5-fluorouracil. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 35(6), 2333\u201348. https:\/\/doi.org\/10.1159\/000374036","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"9829_CR248","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3727\/096504016X14719078133366","volume":"25","author":"Kexin Lou","year":"2017","unstructured":"Lou, K., Chen, N., Li, Z., Zhang, B., Wang, X., Chen, Y., \u2026 Wang, H. (2017). MicroRNA-142-5p overexpression inhibits cell growth and induces apoptosis by regulating FOXO in hepatocellular carcinoma cells. Oncology research, 25(1), 65\u201373. https:\/\/doi.org\/10.3727\/096504016X14719078133366","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"key":"9829_CR249","doi-asserted-by":"publisher","unstructured":"Zhang, J., Shi, Y., Hong, D., Song, M., Huang, D., Wang, C., & Zhao, G. (2015). MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1\/\u03b2-catenin pathway. Scientific reports, 5(1), 8087. https:\/\/doi.org\/10.1038\/srep08087","DOI":"10.1038\/srep08087"},{"key":"9829_CR250","unstructured":"Zhao, Y., Li, F., Zhang, X., Liu, A., Qi, J., Cui, H., & Zhao, P. (2015). MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. International journal of clinical and experimental pathology, 8(10), 12446\u201354. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26722431"},{"issue":"5","key":"9829_CR251","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3892\/mmr.2014.2526","volume":"10","author":"YANG YANG","year":"2014","unstructured":"Yang, Y., Li, M., Chang, S., Wang, L., Song, T., Gao, L., \u2026 Huang, C. (2014). MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Molecular medicine reports, 10(5), 2643\u20138. https:\/\/doi.org\/10.3892\/mmr.2014.2526","journal-title":"Molecular Medicine Reports"},{"key":"9829_CR252","doi-asserted-by":"publisher","unstructured":"Rebucci, M., Sermeus, A., Leonard, E., Delaive, E., Dieu, M., Fransolet, M., \u2026 Michiels, C. (2015). miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1. Molecular cancer, 14(1), 79. https:\/\/doi.org\/10.1186\/s12943-015-0349-6","DOI":"10.1186\/s12943-015-0349-6"},{"issue":"4","key":"9829_CR253","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3892\/or.2016.4550","volume":"35","author":"RONG GUI","year":"2016","unstructured":"Gui, R., Huang, R., Zhang, J.-H., Wen, X.-H., & Nie, X.-M. (2016). MicroRNA-199a-5p inhibits VEGF-induced tumorigenesis through targeting oxidored-nitro domain-containing protein 1 in human HepG2 cells. Oncology reports, 35(4), 2216\u201322. https:\/\/doi.org\/10.3892\/or.2016.4550","journal-title":"Oncology Reports"},{"key":"9829_CR254","doi-asserted-by":"publisher","unstructured":"Dou, C., Wang, Y., Li, C., Liu, Z., Jia, Y., Li, Q., \u2026 Tu, K. (2015). MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget, 6(15), 13216\u201328. https:\/\/doi.org\/10.18632\/oncotarget.3916","DOI":"10.18632\/oncotarget.3916"},{"key":"9829_CR255","doi-asserted-by":"publisher","unstructured":"Tu, H., Wei, G., Cai, Q., Chen, X., Sun, Z., Cheng, C., \u2026 Zeng, T. (2015). MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1. OncoTargets and therapy, 8, 2227\u201335. https:\/\/doi.org\/10.2147\/OTT.S87976","DOI":"10.2147\/OTT.S87976"},{"key":"9829_CR256","unstructured":"Zheng, W.-W., Zhou, J., Zhang, C.-H., & Liu, X.-S. (2016). MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1. European review for medical and pharmacological sciences, 20(12), 2541\u201350. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27383303"},{"issue":"1","key":"9829_CR257","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbrc.2016.12.091","volume":"483","author":"Zheng Dong","year":"2017","unstructured":"Dong, Z., Qi, R., Guo, X., Zhao, X., Li, Y., Zeng, Z., \u2026 Lu, Y. (2017). MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Biochemical and biophysical research communications, 483(1), 630\u2013637. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.091","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR258","doi-asserted-by":"publisher","unstructured":"Fang, L., Zhang, H.-B., Li, H., Fu, Y., & Yang, G.-S. (2012). miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells. Radiology and oncology, 46(3), 233\u201341. https:\/\/doi.org\/10.2478\/v10019-012-0025-z","DOI":"10.2478\/v10019-012-0025-z"},{"issue":"11","key":"9829_CR259","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.1007\/s13277-015-3644-3","volume":"36","author":"Wei Guo","year":"2015","unstructured":"Guo, W., Tan, W., Liu, S., Huang, X., Lin, J., Liang, R., \u2026 Wang, C. (2015). MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(11), 9049\u201357. https:\/\/doi.org\/10.1007\/s13277-015-3644-3","journal-title":"Tumor Biology"},{"issue":"4","key":"9829_CR260","doi-asserted-by":"publisher","first-page":"8556","DOI":"10.3390\/ijms14048556","volume":"14","author":"Xiangxiang Shan","year":"2013","unstructured":"Shan, X., Miao, Y., Fan, R., Qian, H., Chen, P., Liu, H., \u2026 Zhou, F. (2013). MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and inhibition of the Wnt pathway, 14(4). https:\/\/doi.org\/10.3390\/ijms14048556","journal-title":"International Journal of Molecular Sciences"},{"key":"9829_CR261","doi-asserted-by":"publisher","unstructured":"Huang, Y., Liu, J., Fan, L., Wang, F., Yu, H., Wei, W., & Sun, G. (2016). miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. OncoTargets and therapy, 9, 1623\u201333. https:\/\/doi.org\/10.2147\/OTT.S96902","DOI":"10.2147\/OTT.S96902"},{"issue":"1","key":"9829_CR262","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3892\/or.2017.5702","volume":"38","author":"Yuankui Chu","year":"2017","unstructured":"Chu, Y., Fan, W., Guo, W., Zhang, Y., Wang, L., Guo, L., \u2026 Xu, G. (2017). miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3. Oncology reports, 38(1), 343\u2013351. https:\/\/doi.org\/10.3892\/or.2017.5702","journal-title":"Oncology Reports"},{"issue":"5","key":"9829_CR263","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3892\/ijmm.2015.2341","volume":"36","author":"YU LIU","year":"2015","unstructured":"Liu, Y., Liang, H., & Jiang, X. (2015). MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2. International journal of molecular medicine, 36(5), 1345\u201352. https:\/\/doi.org\/10.3892\/ijmm.2015.2341","journal-title":"International Journal of Molecular Medicine"},{"issue":"6","key":"9829_CR264","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3892\/ol.2016.5326","volume":"12","author":"Chengyong Liu","year":"2016","unstructured":"Liu, C., Wang, C., Wang, J., & Huang, H. (2016). miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer. Oncology letters, 12(6), 5177\u20135182. https:\/\/doi.org\/10.3892\/ol.2016.5326","journal-title":"Oncology Letters"},{"issue":"11-12","key":"9829_CR265","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.lfs.2012.08.015","volume":"91","author":"Dong Li","year":"2012","unstructured":"Li, D., Yang, P., Li, H., Cheng, P., Zhang, L., Wei, D., \u2026 Zhang, T. (2012). MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life sciences, 91(11\u201312), 440\u2013447. https:\/\/doi.org\/10.1016\/j.lfs.2012.08.015","journal-title":"Life Sciences"},{"issue":"2","key":"9829_CR266","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3892\/or.2012.1850","volume":"28","author":"WEI WEI","year":"2012","unstructured":"WEI, W., HU, Z., FU, H., TIE, Y., ZHANG, H., WU, Y., & ZHENG, X. (2012). MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Oncology Reports, 28(2), 701\u2013706. https:\/\/doi.org\/10.3892\/or.2012.1850","journal-title":"Oncology Reports"},{"issue":"5","key":"9829_CR267","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s13277-012-0396-1","volume":"33","author":"Qing-jun Li","year":"2012","unstructured":"Li, Q., Zhou, L., Yang, F., Wang, G., Zheng, H., Wang, D., \u2026 Dou, K. (2012). MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells. Tumor Biology, 33(5), 1455\u20131465. https:\/\/doi.org\/10.1007\/s13277-012-0396-1","journal-title":"Tumor Biology"},{"key":"9829_CR268","doi-asserted-by":"publisher","unstructured":"Zeng, Y.-B., Liang, X.-H., Zhang, G.-X., Jiang, N., Zhang, T., Huang, J.-Y., \u2026 Zeng, X.-C. (2016). miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1. Cancer cell international, 16(1), 63. https:\/\/doi.org\/10.1186\/s12935-016-0328-z","DOI":"10.1186\/s12935-016-0328-z"},{"issue":"1","key":"9829_CR269","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00432-011-1076-z","volume":"138","author":"Zhong-Bo Han","year":"2011","unstructured":"Han, Z.-B., Chen, H.-Y., Fan, J.-W., Wu, J.-Y., Tang, H.-M., & Peng, Z.-H. (2012). Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. Journal of Cancer Research and Clinical Oncology, 138(1), 153\u2013161. https:\/\/doi.org\/10.1007\/s00432-011-1076-z","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"9","key":"9829_CR270","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/cncr.26566","volume":"118","author":"Qing Xie","year":"2011","unstructured":"Xie, Q., Chen, X., Lu, F., Zhang, T., Hao, M., Wang, Y., \u2026 Zhuang, H. (2012). Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer, 118(9), 2431\u201342. https:\/\/doi.org\/10.1002\/cncr.26566","journal-title":"Cancer"},{"issue":"6","key":"9829_CR271","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1242\/jcs.122895","volume":"126","author":"S. W. Shan","year":"2013","unstructured":"Shan, S. W., Fang, L., Shatseva, T., Rutnam, Z. J., Yang, X., Du, W., \u2026 Yang, B. B. (2013). Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways, 126. https:\/\/doi.org\/10.1242\/jcs.122895","journal-title":"Journal of Cell Science"},{"key":"9829_CR272","doi-asserted-by":"crossref","unstructured":"Zhang, X., Yu, B., Zhang, F., Guo, Z., & Li, L. (2017). microRNA-18a promotes cell migration and invasion through inhibiting Dicer l expression in hepatocellular carcinoma in vitro. Chinese medical sciences journal = Chung-kuo i hsueh k\u2019o hsueh tsa chih, 32(1), 34\u20133. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28399983","DOI":"10.24920\/J1001-9242.2007.005"},{"issue":"11","key":"9829_CR273","doi-asserted-by":"publisher","first-page":"20486","DOI":"10.3390\/ijms151120486","volume":"15","author":"Kangsheng Tu","year":"2014","unstructured":"Tu, K., Zheng, X., Dou, C., Li, C., Yang, W., Yao, Y., & Liu, Q. (2014). MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. International journal of molecular sciences, 15(11), 20486\u201399. https:\/\/doi.org\/10.3390\/ijms151120486","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"9829_CR274","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/hep.27816","volume":"62","author":"Kuang-Hsiang Chuang","year":"2015","unstructured":"Chuang, K.-H., Whitney-Miller, C. L., Chu, C.-Y., Zhou, Z., Dokus, M. K., Schmit, S., & Barry, C. T. (2015). MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors. Hepatology (Baltimore, Md.), 62(2), 466\u201380. https:\/\/doi.org\/10.1002\/hep.27816","journal-title":"Hepatology"},{"key":"9829_CR275","unstructured":"Li, Z.-B., Li, Z.-Z., Li, L., Chu, H.-T., & Jia, M. (2015). MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells. European review for medical and pharmacological sciences, 19(17), 3208\u201317. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26400524"},{"issue":"4","key":"9829_CR276","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.3892\/mmr.2015.4051","volume":"12","author":"BIJING MAO","year":"2015","unstructured":"Mao, B., Xiao, H., Zhang, Z., Wang, D., & Wang, G. (2015). MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells. Molecular medicine reports, 12(4), 4917\u201324. https:\/\/doi.org\/10.3892\/mmr.2015.4051","journal-title":"Molecular Medicine Reports"},{"issue":"10","key":"9829_CR277","doi-asserted-by":"publisher","first-page":"e77957","DOI":"10.1371\/journal.pone.0077957","volume":"8","author":"Zong-Tao Chai","year":"2013","unstructured":"Chai, Z.-T., Kong, J., Zhu, X.-D., Zhang, Y.-Y., Lu, L., Zhou, J.-M., \u2026 Sun, H.-C. (2013). MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2\u03b1\/Akt\/HIF-1\u03b1 pathway in hepatocellular carcinoma. PloS one, 8(10), e77957. https:\/\/doi.org\/10.1371\/journal.pone.0077957","journal-title":"PLoS ONE"},{"issue":"1","key":"9829_CR278","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1089\/gtmb.2014.0245","volume":"19","author":"Gang Wang","year":"2015","unstructured":"Wang, G., Sun, Y., He, Y., Ji, C., Hu, B., & Sun, Y. (2015). miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2. Genetic testing and molecular biomarkers, 19(1), 30\u20136. https:\/\/doi.org\/10.1089\/gtmb.2014.0245","journal-title":"Genetic Testing and Molecular Biomarkers"},{"key":"9829_CR279","doi-asserted-by":"publisher","unstructured":"Ma, D.-N., Chai, Z.-T., Zhu, X.-D., Zhang, N., Zhan, D.-H., Ye, B.-G., \u2026 Tang, Z.-Y. (2016). MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2, 9(1), 1. https:\/\/doi.org\/10.1186\/s13045-015-0229-y","DOI":"10.1186\/s13045-015-0229-y"},{"issue":"9","key":"9829_CR280","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/aps.2014.59","volume":"35","author":"Yue Wang","year":"2014","unstructured":"Wang, Y., Cui, M., Sun, B., Liu, F., Zhang, X., & Ye, L. (2014). MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3\u2019UTR. Acta pharmacologica Sinica, 35(9), 1207\u201314. https:\/\/doi.org\/10.1038\/aps.2014.59","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1-2","key":"9829_CR281","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2015.11.008","volume":"468","author":"Zhanping Lu","year":"2015","unstructured":"Lu, Z., Zhang, W., Gao, S., Jiang, Q., Xiao, Z., Ye, L., & Zhang, X. (2015). MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochemical and biophysical research communications, 468(1\u20132), 8\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2015.11.008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR282","doi-asserted-by":"publisher","unstructured":"Shen, G., Lin, Y., Yang, X., Zhang, J., Xu, Z., & Jia, H. (2014). MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X. BMC cancer, 14(1), 393. https:\/\/doi.org\/10.1186\/1471-2407-14-393","DOI":"10.1186\/1471-2407-14-393"},{"issue":"1","key":"9829_CR283","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2013.08.032","volume":"439","author":"Jian Wang","year":"2013","unstructured":"Wang, J., Li, J., Wang, X., Zheng, C., & Ma, W. (2013). Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. Biochemical and biophysical research communications, 439(1), 47\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.032","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR284","doi-asserted-by":"publisher","unstructured":"Li, Y., Li, Y., Chen, Y., Xie, Q., Dong, N., Gao, Y., \u2026 Wang, S. (2017). MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis. Cancer cell international, 17(1), 102. https:\/\/doi.org\/10.1186\/s12935-017-0471-1","DOI":"10.1186\/s12935-017-0471-1"},{"issue":"2","key":"9829_CR285","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1159\/000488734","volume":"46","author":"Hongdan Li","year":"2018","unstructured":"Li, H., Wang, H., & Ren, Z. (2018). MicroRNA-214-5p inhibits the invasion and migration of hepatocellular carcinoma cells by targeting Wiskott-Aldrich syndrome like. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 46(2), 757\u2013764. https:\/\/doi.org\/10.1159\/000488734","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"4","key":"9829_CR286","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2016.09.076","volume":"479","author":"Wenxian Cui","year":"2016","unstructured":"Cui, W., Li, Y., Xu, K., Chen, G., Lu, X., Duan, Q., & Kang, Z. (2016). miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA. Biochemical and biophysical research communications, 479(4), 901\u2013906. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.076","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR287","doi-asserted-by":"publisher","unstructured":"Guo, C., Zhao, D., Zhang, Q., Liu, S., & Sun, M.-Z. (2018). miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf\/MEK\/ERK pathway and epithelial-mesenchymal transition. Scientific reports, 8(1), 2375. https:\/\/doi.org\/10.1038\/s41598-018-20258-8","DOI":"10.1038\/s41598-018-20258-8"},{"issue":"40","key":"9829_CR288","doi-asserted-by":"publisher","first-page":"28893","DOI":"10.1074\/jbc.M113.502682","volume":"288","author":"Zhihong Yang","year":"2013","unstructured":"Yang, Z., Tsuchiya, H., Zhang, Y., Hartnett, M. E., & Wang, L. (2013). MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. The Journal of biological chemistry, 288(40), 28893\u20139. https:\/\/doi.org\/10.1074\/jbc.M113.502682","journal-title":"Journal of Biological Chemistry"},{"issue":"1-2","key":"9829_CR289","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-014-2234-9","volume":"399","author":"Jing Xue","year":"2014","unstructured":"Xue, J., Chen, L.-Z., Li, Z.-Z., Hu, Y., Yan, S., & Liu, L.-Y. (2015). MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4). Molecular and cellular biochemistry, 399(1\u20132), 77\u201386. https:\/\/doi.org\/10.1007\/s11010-014-2234-9","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"9829_CR290","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/or.2017.5683","volume":"38","author":"Junjie Mao","year":"2017","unstructured":"Mao, J., Hu, X., Pang, P., Zhou, B., Li, D., & Shan, H. (2017). miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1\/STAT3 pathway. Oncology reports, 38(1), 393\u2013401. https:\/\/doi.org\/10.3892\/or.2017.5683","journal-title":"Oncology Reports"},{"issue":"2","key":"9829_CR291","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbrc.2017.06.050","volume":"490","author":"Guoliang Zhao","year":"2017","unstructured":"Zhao, G., Han, C., Zhang, Z., Wang, L., & Xu, J. (2017). Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Biochemical and biophysical research communications, 490(2), 371\u2013377. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.050","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR292","doi-asserted-by":"publisher","unstructured":"Han, S.-Y., Han, H.-B., Tian, X.-Y., Sun, H., Xue, D., Zhao, C., \u2026 Li, P.-P. (2016). MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma. Oncotarget, 7(27), 42461\u201342473. https:\/\/doi.org\/10.18632\/oncotarget.9886","DOI":"10.18632\/oncotarget.9886"},{"issue":"5","key":"9829_CR293","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3892\/ijmm.2016.2754","volume":"38","author":"Qinggang Tian","year":"2016","unstructured":"Tian, Q., Xiao, Y., Wu, Y., Liu, Y., Song, Z., Gao, W., \u2026 Sun, Z. (2016). MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. International journal of molecular medicine, 38(5), 1587\u20131595. https:\/\/doi.org\/10.3892\/ijmm.2016.2754","journal-title":"International Journal of Molecular Medicine"},{"key":"9829_CR294","unstructured":"Song, J., Wang, Q., Luo, Y., Yuan, P., Tang, C., Hui, Y., & Wang, Z. (2015). miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS. International journal of clinical and experimental pathology, 8(10), 12728\u201337. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26722462"},{"key":"9829_CR295","doi-asserted-by":"publisher","unstructured":"Wang, L., Wu, J., & Xie, C. (2017). miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting. Iranian journal of basic medical sciences, 20(7), 783\u2013790. https:\/\/doi.org\/10.22038\/IJBMS.2017.9010","DOI":"10.22038\/IJBMS.2017.9010"},{"issue":"1","key":"9829_CR296","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3892\/ol.2015.3832","volume":"11","author":"ZHENYU LIU","year":"2015","unstructured":"Liu, Z., Wang, J., Mao, Y., Zou, B., & Fan, X. (2016). MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells. Oncology letters, 11(1), 433\u2013438. https:\/\/doi.org\/10.3892\/ol.2015.3832","journal-title":"Oncology Letters"},{"key":"9829_CR297","doi-asserted-by":"publisher","unstructured":"Cao, K., Li, J., Zhao, Y., Wang, Q., Zeng, Q., He, S., \u2026 Cao, P. (2016). miR-101 inhibiting cell proliferation, migration and invasion in hepatocellular carcinoma through downregulating girdin, 39(2), 96\u2013102. https:\/\/doi.org\/10.14348\/molcells.2016.2161","DOI":"10.14348\/molcells.2016.2161"},{"issue":"6","key":"9829_CR298","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3727\/096504018X15148192843443","volume":"26","author":"Haiyan Jia","year":"2018","unstructured":"Jia, H., Wang, H., Yao, Y., Wang, C., & Li, P. (2018). MiR-136 inhibits malignant progression of hepatocellular carcinoma cells by targeting cyclooxygenase 2. Oncology research, 26(6), 967\u2013976. https:\/\/doi.org\/10.3727\/096504018X15148192843443","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"issue":"15","key":"9829_CR299","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.7150\/jca.25569","volume":"9","author":"Liu Yang","year":"2018","unstructured":"Yang, L., Guo, Y., Liu, X., Wang, T., Tong, X., Lei, K., \u2026 Xu, Q. (2018). The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4. Journal of Cancer, 9(15), 2693\u20132701. https:\/\/doi.org\/10.7150\/jca.25569","journal-title":"Journal of Cancer"},{"issue":"5","key":"9829_CR300","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1007\/s13277-015-4462-3","volume":"37","author":"Wei Ding","year":"2015","unstructured":"Ding, W., Tan, H., Zhao, C., Li, X., Li, Z., Jiang, C., \u2026 Wang, L. (2015). MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumor Biology, 37(5), 1\u20136. https:\/\/doi.org\/10.1007\/s13277-015-4462-3","journal-title":"Tumor Biology"},{"key":"9829_CR301","unstructured":"Zu, Y., Yang, Y., Zhu, J., Bo, X., Hou, S., Zhang, B., \u2026 Zheng, J. (2016). MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. American journal of cancer research, 6(11), 2502\u20132513. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27904767"},{"issue":"2","key":"9829_CR302","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3892\/ijmm.2014.1800","volume":"34","author":"WEIWEI LIU","year":"2014","unstructured":"Liu, W., Xu, C., Wan, H., Liu, C., Wen, C., Lu, H., & Wan, F. (2014). MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells. International journal of molecular medicine, 34(2), 420\u20138. https:\/\/doi.org\/10.3892\/ijmm.2014.1800","journal-title":"International Journal of Molecular Medicine"},{"key":"9829_CR303","doi-asserted-by":"publisher","unstructured":"Jiang, G., Cui, Y., Yu, X., Wu, Z., Ding, G., & Cao, L. (2015). miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Oncotarget, 6(11), 9457\u201366. https:\/\/doi.org\/10.18632\/oncotarget.3265","DOI":"10.18632\/oncotarget.3265"},{"key":"9829_CR304","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/OTT.S122992","volume":"Volume 10","author":"Fei Xie","year":"2017","unstructured":"Xie, F., Yuan, Y., Xie, L., Ran, P., Xiang, X., Huang, Q., \u2026 Zheng, S. (2017). miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma. OncoTargets and therapy, 10, 885\u2013894. https:\/\/doi.org\/10.2147\/OTT.S122992","journal-title":"OncoTargets and Therapy"},{"issue":"8","key":"9829_CR305","doi-asserted-by":"publisher","first-page":"6313","DOI":"10.1007\/s13277-015-3317-2","volume":"36","author":"Hui Liu","year":"2015","unstructured":"Liu, H., Li, W., Chen, C., Pei, Y., & Long, X. (2015). MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma. Tumor Biology, 36(8), 6313\u20136319. https:\/\/doi.org\/10.1007\/s13277-015-3317-2","journal-title":"Tumor Biology"},{"issue":"3","key":"9829_CR306","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3892\/or.2017.5423","volume":"37","author":"Yahui Liu","year":"2017","unstructured":"Liu, Y., Zhang, W., Liu, S., Liu, K., Ji, B., & Wang, Y. (2017). miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma. Oncology reports, 37(3), 1857\u20131864. https:\/\/doi.org\/10.3892\/or.2017.5423","journal-title":"Oncology Reports"},{"issue":"3","key":"9829_CR307","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/febs.13167","volume":"282","author":"Xin-Ping Huang","year":"2014","unstructured":"Huang, X.-P., Hou, J., Shen, X.-Y., Huang, C.-Y., Zhang, X.-H., Xie, Y.-A., & Luo, X.-L. (2015). MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. The FEBS journal, 282(3), 579\u201394. https:\/\/doi.org\/10.1111\/febs.13167","journal-title":"FEBS Journal"},{"issue":"7","key":"9829_CR308","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.prp.2018.04.012","volume":"214","author":"Yizhou Wang","year":"2018","unstructured":"Wang, Y., Xie, Y., Li, X., Lin, J., Zhang, S., Li, Z., \u2026 Gong, R. (2018). MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A. Pathology, research and practice, 214(7), 1024\u20131030. https:\/\/doi.org\/10.1016\/j.prp.2018.04.012","journal-title":"Pathology - Research and Practice"},{"issue":"4","key":"9829_CR309","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/or.2011.1589","volume":"27","author":"LIN FANG","year":"2011","unstructured":"Fang, L., Yang, N., Ma, J., Fu, Y., & Yang, G.-S. (2012). microRNA-1301-mediated inhibition of tumorigenesis. Oncology reports, 27(4), 929\u201334. https:\/\/doi.org\/10.3892\/or.2011.1589","journal-title":"Oncology Reports"},{"issue":"5","key":"9829_CR310","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3892\/etm.2017.4236","volume":"13","author":"Weiping Chang","year":"2017","unstructured":"Chang, W., Zhang, L., Xian, Y., & Yu, Z. (2017). MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPAR\u03b1 in human hepatocellular carcinoma. Experimental and therapeutic medicine, 13(5), 2507\u20132514. https:\/\/doi.org\/10.3892\/etm.2017.4236","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"9829_CR311","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canlet.2008.09.035","volume":"275","author":"Na Li","year":"2009","unstructured":"Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., & Zheng, X. (2009). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer letters, 275(1), 44\u201353. https:\/\/doi.org\/10.1016\/j.canlet.2008.09.035","journal-title":"Cancer Letters"},{"issue":"11-12","key":"9829_CR312","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10528-015-9693-x","volume":"53","author":"Fengyun Wen","year":"2015","unstructured":"Wen, F., Li, B., Huang, C., Wei, Z., Zhou, Y., Liu, J., & Zhang, H. (2015). MiR-34a is involved in the decrease of ATP contents induced by resistin through target on ATP5S in HepG2 cells. Biochemical genetics, 53(11\u201312), 301\u20139. https:\/\/doi.org\/10.1007\/s10528-015-9693-x","journal-title":"Biochemical Genetics"},{"key":"9829_CR313","doi-asserted-by":"publisher","unstructured":"Ye, J., Yao, Y., Song, Q., Li, S., Hu, Z., Yu, Y., \u2026 Wang, Q. K. (2016). Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression. Scientific reports, 6(1), 34034. https:\/\/doi.org\/10.1038\/srep34034","DOI":"10.1038\/srep34034"},{"key":"9829_CR314","unstructured":"Yu, L., Zhou, L., Cheng, Y., Sun, L., Fan, J., Liang, J., \u2026 Zhu, L. (2014). MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma. American journal of cancer research, 4(6), 897\u2013906. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25520877"},{"issue":"3","key":"9829_CR315","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cpr.12181","volume":"48","author":"Tonggang Liu","year":"2015","unstructured":"Liu, T., Zhang, X., Sha, K., Liu, X., Zhang, L., & Wang, B. (2015). miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5. Cell proliferation, 48(3), 330\u20137. https:\/\/doi.org\/10.1111\/cpr.12181","journal-title":"Cell Proliferation"},{"issue":"2","key":"9829_CR316","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3892\/or.2012.2138","volume":"29","author":"DONG XU","year":"2012","unstructured":"Xu, D., He, X., Chang, Y., Xu, C., Jiang, X., Sun, S., & Lin, J. (2013). Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. Oncology reports, 29(2), 653\u201361. https:\/\/doi.org\/10.3892\/or.2012.2138","journal-title":"Oncology Reports"},{"issue":"2","key":"9829_CR317","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biopha.2013.09.005","volume":"68","author":"Bo Gao","year":"2014","unstructured":"Gao, B., Gao, K., Li, L., Huang, Z., & Lin, L. (2014). miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC). Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 68(2), 143\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2013.09.005","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9829_CR318","unstructured":"Zhang, J.-J., Wang, C.-Y., Hua, L., Yao, K.-H., Chen, J.-T., & Hu, J.-H. (2015). miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2. International journal of clinical and experimental pathology, 8(5), 5168\u201374. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26191213"},{"issue":"12","key":"9829_CR319","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/j.1742-4658.2011.08120.x","volume":"278","author":"Nannan Wu","year":"2011","unstructured":"Wu, N., Liu, X., Xu, X., Fan, X., Liu, M., Li, X., \u2026 Tang, H. (2011). MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma. The FEBS journal, 278(12), 2044\u201354. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08120.x","journal-title":"FEBS Journal"},{"issue":"8","key":"9829_CR320","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/aps.2017.62","volume":"38","author":"Shu-qin Zhang","year":"2017","unstructured":"Zhang, S., Yang, Z., Cai, X., Zhao, M., Sun, M.-M., Li, J., \u2026 Zhang, X. (2017). miR-511 promotes the proliferation of human hepatoma cells by targeting the 3\u2032UTR of B cell translocation gene 1 (BTG1) mRNA, 38(8), 1161\u20131170. https:\/\/doi.org\/10.1038\/aps.2017.62","journal-title":"Acta Pharmacologica Sinica"},{"issue":"2","key":"9829_CR321","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbrc.2012.08.075","volume":"426","author":"Qingbo Lang","year":"2012","unstructured":"Lang, Q., & Ling, C. (2012). MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA., 426(2). https:\/\/doi.org\/10.1016\/j.bbrc.2012.08.075","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR322","unstructured":"Zhao, L., & Wang, W. (2015). miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7. International journal of clinical and experimental medicine, 8(10), 18469\u201375. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26770454"},{"issue":"2","key":"9829_CR323","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3892\/or.2016.5290","volume":"37","author":"Jiejing Zhou","year":"2016","unstructured":"Zhou, J., Zhang, Y., Qi, Y., Yu, D., Shao, Q., & Liang, J. (2017). MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma. Oncology reports, 37(2), 1227\u20131234. https:\/\/doi.org\/10.3892\/or.2016.5290","journal-title":"Oncology Reports"},{"issue":"5","key":"9829_CR324","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.3892\/mmr.2016.4995","volume":"13","author":"XING-YU LI","year":"2016","unstructured":"Li, X.-Y., Feng, X.-Z., Tang, J.-Z., Dong, K., Wang, J.-F., Meng, C.-C., \u2026 Sun, Z.-W. (2016). MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a. Molecular medicine reports, 13(5), 3929\u201335. https:\/\/doi.org\/10.3892\/mmr.2016.4995","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"9829_CR325","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/cbf.2863","volume":"31","author":"Wang Wei","year":"2012","unstructured":"Wei, W., Wanjun, L., Hui, S., Dongyue, C., Xinjun, Y., & Jisheng, Z. (2013). miR-203 inhibits proliferation of HCC cells by targeting survivin. Cell biochemistry and function, 31(1), 82\u20135. https:\/\/doi.org\/10.1002\/cbf.2863","journal-title":"Cell Biochemistry and Function"},{"issue":"1-2","key":"9829_CR326","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11010-017-3176-9","volume":"441","author":"Annie Zhang","year":"2017","unstructured":"Zhang, A., Lakshmanan, J., Motameni, A., & Harbrecht, B. G. (2018). MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling. Molecular and cellular biochemistry, 441(1\u20132), 89\u201398. https:\/\/doi.org\/10.1007\/s11010-017-3176-9","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"9829_CR327","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3892\/ijo.2015.3112","volume":"47","author":"KAI LIU","year":"2015","unstructured":"Liu, K., Li, X., Cao, Y., Ge, Y., Wang, J., & Shi, B. (2015). MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3. International journal of oncology, 47(4), 1585\u201393. https:\/\/doi.org\/10.3892\/ijo.2015.3112","journal-title":"International Journal of Oncology"},{"issue":"12","key":"9829_CR328","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1007\/s13277-015-3749-8","volume":"36","author":"Wei Zhang","year":"2015","unstructured":"Zhang, W., Liu, K., Liu, S., Ji, B., Wang, Y., & Liu, Y. (2015). MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(12), 9779\u201388. https:\/\/doi.org\/10.1007\/s13277-015-3749-8","journal-title":"Tumor Biology"},{"issue":"5","key":"9829_CR329","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.3892\/mmr.2015.3232","volume":"11","author":"XIAN CHEN","year":"2015","unstructured":"Chen, X., Bo, L., Zhao, X., & Chen, Q. (2015). MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma. Molecular medicine reports, 11(5), 3900\u20137. https:\/\/doi.org\/10.3892\/mmr.2015.3232","journal-title":"Molecular Medicine Reports"},{"issue":"6","key":"9829_CR330","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.3892\/or.2015.4321","volume":"34","author":"Xiaoli Pang","year":"2015","unstructured":"Pang, X., Huang, K., Zhang, Q., Zhang, Y., & Niu, J. (2015). miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncology reports, 34(6), 3272\u20139. https:\/\/doi.org\/10.3892\/or.2015.4321","journal-title":"Oncology Reports"},{"issue":"2","key":"9829_CR331","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2016.03.027","volume":"343","author":"Zhijie Tian","year":"2016","unstructured":"Tian, Z., Jiang, H., Liu, Y., Huang, Y., Xiong, X., Wu, H., & Dai, X. (2016). MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. Experimental cell research, 343(2), 135\u2013147. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.027","journal-title":"Experimental Cell Research"},{"issue":"8","key":"9829_CR332","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3727\/096504017X14850151453092","volume":"25","author":"Hui Li","year":"2017","unstructured":"Li, H., Xiang, Z., Liu, Y., Xu, B., & Tang, J. (2017). MicroRNA-133b inhibits proliferation, cellular migration, and invasion via targeting LASP1 in hepatocarcinoma cells. Oncology research, 25(8), 1269\u20131282. https:\/\/doi.org\/10.3727\/096504017X14850151453092","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"issue":"10","key":"9829_CR333","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1007\/s13277-016-5230-8","volume":"37","author":"Min Zhu","year":"2016","unstructured":"Zhu, M., Li, M., Wang, T., Linghu, E., & Wu, B. (2016). MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 37(10), 13995\u201314008. https:\/\/doi.org\/10.1007\/s13277-016-5230-8","journal-title":"Tumor Biology"},{"key":"9829_CR334","doi-asserted-by":"publisher","unstructured":"Cui, S., Sun, Y., Liu, Y., Liu, C., Wang, J., Hao, G., & Sun, Q. (2018). [Corrigendum] MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2. Molecular medicine reports, 17(5), 7460. https:\/\/doi.org\/10.3892\/mmr.2018.8785","DOI":"10.3892\/mmr.2018.8785"},{"key":"9829_CR335","unstructured":"Liu, X., Gong, J., & Xu, B. (2015). miR-143 down-regulates TLR2 expression in hepatoma cells and inhibits hepatoma cell proliferation and invasion. International journal of clinical and experimental pathology, 8(10), 12738\u201347. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26722463"},{"issue":"6","key":"9829_CR336","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3892\/etm.2017.4348","volume":"13","author":"Feng Xue","year":"2017","unstructured":"Xue, F., Yin, J., Xu, L., & Wang, B. (2017). MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6. Experimental and therapeutic medicine, 13(6), 2667\u20132674. https:\/\/doi.org\/10.3892\/etm.2017.4348","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"9829_CR337","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.3892\/mmr.2015.4012","volume":"12","author":"LI WANG","year":"2015","unstructured":"Wang, L., Wang, Y. M., Xu, S., Wang, W. G., Chen, Y., MAO, J. Y., \u2026 Le Tian, B. (2015). MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues, 12(4). https:\/\/doi.org\/10.3892\/mmr.2015.4012","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"9829_CR338","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1440-1746.2009.05971.x","volume":"25","author":"Qiong Li","year":"2010","unstructured":"Li, Q., Wang, G., Shan, J.-L., Yang, Z.-X., Wang, H.-Z., Feng, J., \u2026 Wang, D. (2010). MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. Journal of gastroenterology and hepatology, 25(1), 164\u201371. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05971.x","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"9829_CR339","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/ol.2012.742","volume":"4","author":"DONGLAI MA","year":"2012","unstructured":"Ma, D., Tao, X., Gao, F., Fan, C., & Wu, D. (2012). miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncology letters, 4(3), 483\u2013488. https:\/\/doi.org\/10.3892\/ol.2012.742","journal-title":"Oncology Letters"},{"issue":"12","key":"9829_CR340","doi-asserted-by":"publisher","first-page":"e115565","DOI":"10.1371\/journal.pone.0115565","volume":"9","author":"Haitao Xu","year":"2014","unstructured":"Xu, H., Zhao, L., Fang, Q., Sun, J., Zhang, S., Zhan, C., \u2026 Zhang, Y. (2014). MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1\u03b1. PloS one, 9(12), e115565. https:\/\/doi.org\/10.1371\/journal.pone.0115565","journal-title":"PLoS ONE"},{"key":"9829_CR341","doi-asserted-by":"publisher","unstructured":"Xiao, Y., Tian, Q., He, J., Huang, M., Yang, C., & Gong, L. (2016). MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor. OncoTargets and therapy, 9, 3535\u201344. https:\/\/doi.org\/10.2147\/OTT.S106351","DOI":"10.2147\/OTT.S106351"},{"issue":"1","key":"9829_CR342","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3892\/or.2016.5220","volume":"37","author":"Xiaoyan Yang","year":"2016","unstructured":"Yang, X., Zang, J., Pan, X., Yin, J., Xiang, Q., Yu, J., \u2026 Lei, X. (2017). miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E. Oncology reports, 37(1), 563\u2013570. https:\/\/doi.org\/10.3892\/or.2016.5220","journal-title":"Oncology Reports"},{"issue":"3","key":"9829_CR343","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/ijo.2017.3852","volume":"50","author":"Miao Yu","year":"2017","unstructured":"Yu, M., Xue, H., Wang, Y., Shen, Q., Jiang, Q., Zhang, X., Tian, Y. (2017). miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR\/STAT3\/AKT pathway in hepatocellular carcinoma. International journal of oncology, 50(3), 975\u2013983. https:\/\/doi.org\/10.3892\/ijo.2017.3852","journal-title":"International Journal of Oncology"},{"issue":"1-2","key":"9829_CR344","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11010-013-1940-z","volume":"389","author":"Qingliang Zheng","year":"2014","unstructured":"Zheng, Q., Sheng, Q., Jiang, C., Shu, J., Chen, J., Nie, Z., Zhang, Y. (2014). MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B. Molecular and cellular biochemistry, 389(1\u20132), 187\u201395. https:\/\/doi.org\/10.1007\/s11010-013-1940-z","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6","key":"9829_CR345","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/1533034617735931","volume":"16","author":"Hui Tang","year":"2017","unstructured":"Tang, H., Zhang, J., Yu, Z., Ye, L., Li, K., Ding, F., Meng, W. (2017). Mir-452-3p: a potential tumor promoter that targets the CPEB3\/EGFR axis in human hepatocellular carcinoma. Technology in cancer research & treatment, 16(6), 1136\u20131149. https:\/\/doi.org\/10.1177\/1533034617735931","journal-title":"Technology in Cancer Research & Treatment"},{"key":"9829_CR346","doi-asserted-by":"publisher","unstructured":"Yu, L., Gong, X., Sun, L., Yao, H., Lu, B., & Zhu, L. (2015). miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma. Oncotarget, 6(36), 39225\u201334. https:\/\/doi.org\/10.18632\/oncotarget.4407","DOI":"10.18632\/oncotarget.4407"},{"issue":"8","key":"9829_CR347","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/liv.12190","volume":"33","author":"Yun Zhou","year":"2013","unstructured":"Zhou, Y., Li, Y., Ye, J., Jiang, R., Yan, H., Yang, X., \u2026 Zhang, J. (2013). MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Liver international: official journal of the International Association for the Study of the Liver, 33(8), 1271\u201380. https:\/\/doi.org\/10.1111\/liv.12190","journal-title":"Liver International"},{"issue":"23","key":"9829_CR348","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.3748\/wjg.v22.i23.5364","volume":"22","author":"Ge Zhao","year":"2016","unstructured":"Zhao, G., Wang, T., Huang, Q.-K., Pu, M., Sun, W., Zhang, Z.-C., Tao, K.-S. (2016). MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. World journal of gastroenterology, 22(23), 5364\u201373. https:\/\/doi.org\/10.3748\/wjg.v22.i23.5364","journal-title":"World Journal of Gastroenterology"},{"key":"9829_CR349","unstructured":"Li, X., Zhang, W., Zhou, L., Yue, D., & Su, X. (2015). MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2. International journal of clinical and experimental pathology, 8(10), 12455\u201363. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26722432"},{"issue":"6","key":"9829_CR350","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1159\/000489594","volume":"46","author":"Guoyong Han","year":"2018","unstructured":"Han, G., Zhang, L., Ni, X., Chen, Z., Pan, X., Zhu, Q., Wang, X. (2018). MicroRNA-873 promotes cell proliferation, migration, and invasion by directly targeting TSLC1 in hepatocellular carcinoma. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 46(6), 2261\u20132270. https:\/\/doi.org\/10.1159\/000489594","journal-title":"Cellular Physiology and Biochemistry"},{"key":"9829_CR351","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijbiomac.2016.01.019","volume":"86","author":"Sen Lu","year":"2016","unstructured":"Lu, S., Wu, J., Gao, Y., Han, G., Ding, W., & Huang, X. (2016). MicroRNA-4262 activates the NF-\u03baB and enhances the proliferation of hepatocellular carcinoma cells. International journal of biological macromolecules, 86, 43\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.01.019","journal-title":"International Journal of Biological Macromolecules"},{"issue":"4","key":"9829_CR352","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrc1041","volume":"3","author":"Ruth Etzioni","year":"2003","unstructured":"Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Hartwell, L. (2003). The case for early detection. Nature reviews. Cancer, 3(4), 243\u201352. https:\/\/doi.org\/10.1038\/nrc1041","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"9829_CR353","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1158\/1055-9965.EPI-14-0669","volume":"24","author":"M. J. Murray","year":"2014","unstructured":"Murray, M. J., Raby, K. L., Saini, H. K., Bailey, S., Wool, S. V, Tunnacliffe, J. M., Coleman, N. (2015). Solid tumors of childhood display specific serum microRNA profiles. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 24(2), 350\u201360. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0669","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"issue":"5","key":"9829_CR354","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/ijms17050627","volume":"17","author":"Erika Larrea","year":"2016","unstructured":"Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Lawrie, C. H. (2016). New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies, 17(5), 627. https:\/\/doi.org\/10.3390\/ijms17050627","journal-title":"International Journal of Molecular Sciences"},{"key":"9829_CR355","doi-asserted-by":"publisher","unstructured":"Pezuk, J. A., Miller, T. L. A., Bevilacqua, J. L. B., de Barros, A. C. S. D., de Andrade, F. E. M., E Macedo, L. F. de A., Reis, L. F. L. (2017). Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography. Oncotarget, 8(48), 83940\u201383948. https:\/\/doi.org\/10.18632\/oncotarget.20806","DOI":"10.18632\/oncotarget.20806"},{"issue":"6","key":"9829_CR356","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"Hadi Valadi","year":"2007","unstructured":"Valadi, H., Ekstr\u00f6m, K., Bossios, A., Sj\u00f6strand, M., Lee, J. J., & L\u00f6tvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology, 9(6), 654\u20139. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nature Cell Biology"},{"issue":"30","key":"9829_CR357","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"P. S. Mitchell","year":"2008","unstructured":"Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Tewari, M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A., 105(30), 10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"9829_CR358","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","volume":"54","author":"Stephen S C Chim","year":"2008","unstructured":"Chim, S. S. C., Shing, T. K. F., Hung, E. C. W., Leung, T. -y., Lau, T. -k., Chiu, R. W. K., & Dennis Lo, Y. M. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry, 54(3), 482\u2013490. https:\/\/doi.org\/10.1373\/clinchem.2007.097972","journal-title":"Clinical Chemistry"},{"issue":"12","key":"9829_CR359","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"J. D. Arroyo","year":"2011","unstructured":"Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., \u2026 Tewari, M. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, 108(12), 5003\u20138. https:\/\/doi.org\/10.1073\/pnas.1019055108","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9829_CR360","doi-asserted-by":"publisher","unstructured":"Noferesti, S. S., Sohel, M. M. H., Hoelker, M., Salilew-Wondim, D., Tholen, E., Looft, C., \u2026 Tesfaye, D. (2015). Controlled ovarian hyperstimulation induced changes in the expression of circulatory miRNA in bovine follicular fluid and blood plasma. Journal of ovarian research, 8(1), 81. https:\/\/doi.org\/10.1186\/s13048-015-0208-5","DOI":"10.1186\/s13048-015-0208-5"},{"issue":"8","key":"9829_CR361","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","volume":"8","author":"Maria Angelica Cortez","year":"2011","unstructured":"Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., & Calin, G. A. (2011). MicroRNAs in body fluids\u2014the mix of hormones and biomarkers. Nature Reviews Clinical Oncology, 8(8), 467\u2013477. https:\/\/doi.org\/10.1038\/nrclinonc.2011.76","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"11","key":"9829_CR362","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","volume":"37","author":"Andrey Turchinovich","year":"2012","unstructured":"Turchinovich, A., Weiz, L., & Burwinkel, B. (2012). Extracellular miRNAs: the mystery of their origin and function, 37(11). https:\/\/doi.org\/10.1016\/j.tibs.2012.08.003","journal-title":"Trends in Biochemical Sciences"},{"issue":"2","key":"9829_CR363","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-015-3591-0","volume":"154","author":"Lei Zhang","year":"2015","unstructured":"Zhang, L., Xu, Y., Jin, X., Wang, Z., Wu, Y., Zhao, D., Liang, Z. (2015). A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer. Breast Cancer Research and Treatment, 154(2), 423\u2013434. https:\/\/doi.org\/10.1007\/s10549-015-3591-0","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"9829_CR364","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3892\/ol.2016.5462","volume":"13","author":"Hui Zhang","year":"2016","unstructured":"Zhang, H., Mao, F., Shen, T., Luo, Q., Ding, Z., Qian, L., & Huang, J. (2017). Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer. Oncology letters, 13(2), 669\u2013676. https:\/\/doi.org\/10.3892\/ol.2016.5462","journal-title":"Oncology Letters"},{"key":"9829_CR365","doi-asserted-by":"publisher","unstructured":"Wang, J., Yan, F., Zhao, Q., Zhan, F., Wang, R., Wang, L., Huang, X. (2017). Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer. Scientific reports, 7(1), 4150. https:\/\/doi.org\/10.1038\/s41598-017-04386-1","DOI":"10.1038\/s41598-017-04386-1"},{"key":"9829_CR366","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cancergen.2017.07.006","volume":"216-217","author":"Ayda Arab","year":"2017","unstructured":"Arab, A., Karimipoor, M., Irani, S., Kiani, A., Zeinali, S., Tafsiri, E., & Sheikhy, K. (2017). Potential circulating miRNA signature for early detection of NSCLC. Cancer genetics, 216\u2013217, 150\u2013158. https:\/\/doi.org\/10.1016\/j.cancergen.2017.07.006","journal-title":"Cancer Genetics"},{"key":"9829_CR367","doi-asserted-by":"publisher","unstructured":"Wang, Y., Yin, W., Lin, Y., Yin, K., Zhou, L., Du, Y., Lu, J. (2018). Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer. Cell death discovery, 5(1), 21. https:\/\/doi.org\/10.1038\/s41420-018-0089-7","DOI":"10.1038\/s41420-018-0089-7"},{"issue":"10","key":"9829_CR368","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"Gloria Bertoli","year":"2015","unstructured":"Bertoli, G., Cava, C., & Castiglioni, I. (2015). Micrornas: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics, 5(10), 1122\u20131143. https:\/\/doi.org\/10.7150\/thno.11543","journal-title":"Theranostics"},{"issue":"1","key":"9829_CR369","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbcan.2014.10.005","volume":"1855","author":"Ma\u0161a Ale\u010dkovi\u0107","year":"2015","unstructured":"Ale\u010dkovi\u0107, M., & Kang, Y. (2015). Regulation of cancer metastasis by cell-free miRNAs. Biochimica et biophysica acta, 1855(1), 24\u201342. https:\/\/doi.org\/10.1016\/j.bbcan.2014.10.005","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"9829_CR370","doi-asserted-by":"publisher","unstructured":"Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clinical epigenetics, 10(1), 59. https:\/\/doi.org\/10.1186\/s13148-018-0492-1","DOI":"10.1186\/s13148-018-0492-1"},{"issue":"1","key":"9829_CR371","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","volume":"61","author":"Kenneth W Witwer","year":"2015","unstructured":"Witwer, K. W. (2015). Circulating microRNA biomarker studies: pitfalls and potential solutions. Clinical chemistry, 61(1), 56\u201363. https:\/\/doi.org\/10.1373\/clinchem.2014.221341","journal-title":"Clinical Chemistry"},{"issue":"5-6","key":"9829_CR372","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10585-018-9918-6","volume":"35","author":"Stanley P. Leong","year":"2018","unstructured":"Leong, S. P., Ballesteros-Merino, C., Jensen, S. M., Marwitz, S., Bifulco, C., Fox, B. A., & Skoberne, M. (2018). Novel frontiers in detecting cancer metastasis. Clin Exp Metastasis, 35(5\u20136), 403\u2013412. https:\/\/doi.org\/10.1007\/s10585-018-9918-6","journal-title":"Clinical & Experimental Metastasis"},{"issue":"4","key":"9829_CR373","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/10428194.2018.1508668","volume":"60","author":"Maria Chaudhry","year":"2018","unstructured":"Chaudhry, M., Steiner, R., Claussen, C., Patel, K., Lee, H., Weber, D., Manasanch, E. E. (2018). Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenstr\u00f6m\u2019s macroglobulinemia. Leukemia & lymphoma, 1\u20137. https:\/\/doi.org\/10.1080\/10428194.2018.1508668","journal-title":"Leukemia & Lymphoma"},{"key":"9829_CR374","unstructured":"Haug, B. H., Hald, \u00d8. H., Utnes, P., Roth, S. A., L\u00f8kke, C., Fl\u00e6gstad, T., & Einvik, C. (2015). Exosome-like extracellular vesicles from MYCN-amplified neuroblastoma cells contain oncogenic miRNAs. Anticancer Research, 35(5), 2521\u20132530."},{"key":"9829_CR375","doi-asserted-by":"publisher","unstructured":"Ramraj, S. K., Aravindan, S., Somasundaram, D. B., Herman, T. S., Natarajan, M., & Aravindan, N. (2016). Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease. Oncotarget, 7(14), 18605\u201319. https:\/\/doi.org\/10.18632\/oncotarget.7615","DOI":"10.18632\/oncotarget.7615"},{"key":"9829_CR376","doi-asserted-by":"publisher","unstructured":"Zeka, F., Decock, A., Van Goethem, A., Vanderheyden, K., Demuynck, F., Lammens, T., \u2026 Vandesompele, J. (2018). Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients. JCI insight, 3(23). https:\/\/doi.org\/10.1172\/jci.insight.97021","DOI":"10.1172\/jci.insight.97021"},{"key":"9829_CR377","doi-asserted-by":"publisher","unstructured":"Ma, J., Xu, M., Yin, M., Hong, J., Chen, H., Gao, Y., Mo, X. (2019). Exosomal hsa-miR199a-3p promotes proliferation and migration in neuroblastoma. Frontiers in oncology, 9, 459. https:\/\/doi.org\/10.3389\/fonc.2019.00459","DOI":"10.3389\/fonc.2019.00459"},{"issue":"8","key":"9829_CR378","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/pbc.25481","volume":"62","author":"Nicole Ludwig","year":"2015","unstructured":"Ludwig, N., Nourkami-Tutdibi, N., Backes, C., Lenhof, H.-P., Graf, N., Keller, A., & Meese, E. (2015). Circulating serum miRNAs as potential biomarkers for nephroblastoma. Pediatric blood & cancer, 62(8), 1360\u20137. https:\/\/doi.org\/10.1002\/pbc.25481","journal-title":"Pediatric Blood & Cancer"},{"issue":"11","key":"9829_CR379","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00383-016-3960-8","volume":"32","author":"Wanbo Liu","year":"2016","unstructured":"Liu, W., Chen, S., & Liu, B. (2016). Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatric surgery international, 32(11), 1059\u20131065. https:\/\/doi.org\/10.1007\/s00383-016-3960-8","journal-title":"Pediatric Surgery International"},{"issue":"6","key":"9829_CR380","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","volume":"154","author":"Dhaval Patel","year":"2013","unstructured":"Patel, D., Boufraqech, M., Jain, M., Zhang, L., He, M., Gesuwan, K., Kebebew, E. (2013). MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery, 154(6). https:\/\/doi.org\/10.1016\/j.surg.2013.06.022","journal-title":"Surgery"},{"key":"9829_CR381","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jbiotec.2019.03.017","volume":"297","author":"Abel Decmann","year":"2019","unstructured":"Decmann, A., Bancos, I., Khanna, A., Thomas, M. A., Turai, P., Perge, P., Igaz, P. (2019). Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy. Journal of Biotechnology, 297, 49\u201353. https:\/\/doi.org\/10.1016\/j.jbiotec.2019.03.017","journal-title":"Journal of Biotechnology"},{"key":"9829_CR382","doi-asserted-by":"publisher","unstructured":"Pezzuto, F., Buonaguro, L., Buonaguro, F. M., & Tornesello, M. L. (2018). The role of circulating free DNA and microRNA in non-invasive diagnosis of HBV- and HCV-related hepatocellular carcinoma. International Journal of Molecular Sciences, 19(4), 1007. https:\/\/doi.org\/10.3390\/ijms19041007","DOI":"10.3390\/ijms19041007"},{"issue":"5","key":"9829_CR383","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/15384047.2018.1423922","volume":"19","author":"Lobna Mourad","year":"2018","unstructured":"Mourad, L., El-Ahwany, E., Zoheiry, M., Abu-Taleb, H., Hassan, M., Ouf, A., Zada, S. (2018). Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular carcinoma in Egyptian patients. Cancer biology & therapy, 19(5), 400\u2013406. https:\/\/doi.org\/10.1080\/15384047.2018.1423922","journal-title":"Cancer Biology & Therapy"},{"issue":"4","key":"9829_CR384","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.clinre.2017.06.004","volume":"41","author":"Hamdy E. Abouzeid Ali","year":"2017","unstructured":"Ali, H. E. A., Abdel Hameed, R., Effat, H., Ahmed, E. K., Atef, A. A., Sharawi, S. K., \u2026 Abdel Wahab, A. H. (2017). Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Clinics and research in hepatology and gastroenterology, 41(4), e51\u2013e62. https:\/\/doi.org\/10.1016\/j.clinre.2017.06.004","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"9829_CR385","doi-asserted-by":"publisher","unstructured":"Huang, Y.-H., Liang, K.-H., Chien, R.-N., Hu, T.-H., Lin, K.-H., Hsu, C.-W., Yeh, C.-T. (2017). A circulating microRNA signature capable of assessing the risk of hepatocellular carcinoma in cirrhotic patients. Scientific reports, 7(1), 523. https:\/\/doi.org\/10.1038\/s41598-017-00631-9","DOI":"10.1038\/s41598-017-00631-9"},{"issue":"2","key":"9829_CR386","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000449475","volume":"6","author":"Naoshi Nishida","year":"2016","unstructured":"Nishida, N., Arizumi, T., Hagiwara, S., Ida, H., Sakurai, T., & Kudo, M. (2017). MicroRNAs for the prediction of early response to sorafenib treatment in human hepatocellular carcinoma. Liver cancer, 6(2), 113\u2013125. https:\/\/doi.org\/10.1159\/000449475","journal-title":"Liver Cancer"},{"issue":"6","key":"9829_CR387","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1002\/jcb.26650","volume":"119","author":"Min Shi","year":"2018","unstructured":"Shi, M., Jiang, Y., Yang, L., Yan, S., Wang, Y.-G., & Lu, X.-J. (2018). Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma. Journal of cellular biochemistry, 119(6), 4711\u20134716. https:\/\/doi.org\/10.1002\/jcb.26650","journal-title":"Journal of Cellular Biochemistry"},{"key":"9829_CR388","doi-asserted-by":"publisher","unstructured":"Ding, Y., Yan, J.-L., Fang, A.-N., Zhou, W.-F., & Huang, L. (2017). Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles. Oncotarget, 8(39), 66402\u201366413. https:\/\/doi.org\/10.18632\/oncotarget.18949","DOI":"10.18632\/oncotarget.18949"},{"issue":"34","key":"9829_CR389","doi-asserted-by":"publisher","first-page":"9853","DOI":"10.3748\/wjg.v21.i34.9853","volume":"21","author":"Yu-Cheng Zhang","year":"2015","unstructured":"Zhang, Y.-C., Xu, Z., Zhang, T.-F., & Wang, Y.-L. (2015). Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World journal of gastroenterology, 21(34), 9853\u201362. https:\/\/doi.org\/10.3748\/wjg.v21.i34.9853","journal-title":"World Journal of Gastroenterology"},{"key":"9829_CR390","doi-asserted-by":"publisher","unstructured":"Moshiri, F., Salvi, A., Gramantieri, L., Sangiovanni, A., Guerriero, P., De Petro, G., \u2026 Negrini, M. (2018). Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget, 9(20), 15350\u201315364. https:\/\/doi.org\/10.18632\/oncotarget.24601","DOI":"10.18632\/oncotarget.24601"},{"issue":"4","key":"9829_CR391","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3892\/or.2016.5026","volume":"36","author":"Dian Yin","year":"2016","unstructured":"Yin, D., Wang, Y., Sai, W., Zhang, L., Miao, Y., Cao, L., \u2026 Yang, L. (2016). Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma, 36(4). https:\/\/doi.org\/10.3892\/or.2016.5026","journal-title":"Oncology Reports"},{"key":"9829_CR392","unstructured":"Simonson, B., & Das, S. (2015). MicroRNA therapeutics: the next magic bullet? Mini reviews in medicinal chemistry, 15(6), 467\u201374. Retrieved from http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4410078"},{"issue":"4","key":"9829_CR393","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.bbrc.2006.12.135","volume":"353","author":"Valia Bravo","year":"2007","unstructured":"Bravo, V., Rosero, S., Ricordi, C., & Pastori, R. L. (2007). Instability of miRNA and cDNAs derivatives in RNA preparations. Biochemical and biophysical research communications, 353(4), 1052\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2006.12.135","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9829_CR394","unstructured":"Nguyen, T., Menocal, E. M., Harborth, J., & Fruehauf, J. H. (2008). RNAi therapeutics: an update on delivery. Current opinion in molecular therapeutics, 10(2), 158\u201367. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18386228"},{"issue":"18","key":"9829_CR395","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"Harry L.A. Janssen","year":"2013","unstructured":"Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., \u2026 Hodges, M. R. (2013). Treatment of HCV infection by targeting microRNA. The New England journal of medicine, 368(18), 1685\u201394. https:\/\/doi.org\/10.1056\/NEJMoa1209026","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"9829_CR396","doi-asserted-by":"publisher","first-page":"e38129","DOI":"10.1371\/journal.pone.0038129","volume":"7","author":"Amanda Tivnan","year":"2012","unstructured":"Tivnan, A., Orr, W. S., Gubala, V., Nooney, R., Williams, D. E., McDonagh, C., \u2026 Stallings, R. L. (2012). Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PloS one, 7(5), e38129. https:\/\/doi.org\/10.1371\/journal.pone.0038129","journal-title":"PLoS ONE"},{"issue":"8","key":"9829_CR397","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.nano.2013.05.007","volume":"9","author":"Shu-hao Hsu","year":"2013","unstructured":"Hsu, S., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., \u2026 Ghoshal, K. (2013). Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine: nanotechnology, biology, and medicine, 9(8), 1169\u201380. https:\/\/doi.org\/10.1016\/j.nano.2013.05.007","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"9829_CR398","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2147\/IJN.S157805","volume":"Volume 13","author":"Feng Li","year":"2018","unstructured":"Li, F., Wang, F., Zhu, C., Wei, Q., Zhang, T., & Zhou, Y. L. (2018). miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker. International journal of nanomedicine, 13, 2295\u20132307. https:\/\/doi.org\/10.2147\/IJN.S157805","journal-title":"International Journal of Nanomedicine"},{"key":"9829_CR399","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jconrel.2015.11.015","volume":"220","author":"Justyna M. Meissner","year":"2015","unstructured":"Meissner, J. M., Toporkiewicz, M., Czogalla, A., Matusewicz, L., Kuliczkowski, K., & Sikorski, A. F. (2015). Novel antisense therapeutics delivery systems: in vitro and in vivo studies of liposomes targeted with anti-CD20 antibody. Journal of controlled release: official journal of the Controlled Release Society, 220(Pt A), 515\u2013528. https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.015","journal-title":"Journal of Controlled Release"},{"issue":"11-12","key":"9829_CR400","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jgm.2810","volume":"16","author":"Asli Ekin","year":"2014","unstructured":"Ekin, A., Karatas, O. F., Culha, M., & Ozen, M. (2014). Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells. The journal of gene medicine, 16(11\u201312), 331\u20135. https:\/\/doi.org\/10.1002\/jgm.2810","journal-title":"The Journal of Gene Medicine"},{"key":"9829_CR401","doi-asserted-by":"publisher","first-page":"103165","DOI":"10.1016\/j.bioorg.2019.103165","volume":"91","author":"Valerio Piacenti","year":"2019","unstructured":"Piacenti, V., Langella, E., Autiero, I., Nolan, J. C., Piskareva, O., Adamo, M. F. A., \u2026 Moccia, M. (2019). A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a. Bioorganic Chemistry, 91, 103165. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103165","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"9829_CR402","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/nar\/gkt852","volume":"42","author":"Luca F. R. Gebert","year":"2013","unstructured":"Gebert, L. F. R., Rebhan, M. A. E., Crivelli, S. E. M., Denzler, R., Stoffel, M., & Hall, J. (2014). Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic acids research, 42(1), 609\u201321. https:\/\/doi.org\/10.1093\/nar\/gkt852","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"9829_CR403","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/apt.13432","volume":"43","author":"M. H. van der Ree","year":"2015","unstructured":"van der Ree, M. H., van der Meer, A. J., van Nuenen, A. C., de Bruijne, J., Ottosen, S., Janssen, H. L., \u2026 Reesink, H. W. (2016). Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma. Alimentary Pharmacology & Therapeutics, 43(1), 102\u2013113. https:\/\/doi.org\/10.1111\/apt.13432","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"9829_CR404","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1128\/AAC.04220-14","volume":"59","author":"S\u00f8ren Ottosen","year":"2014","unstructured":"Ottosen, S., Parsley, T. B., Yang, L., Zeh, K., van Doorn, L.-J., van der Veer, E., \u2026 Patick, A. K. (2015). In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrobial agents and chemotherapy, 59(1), 599\u2013608. https:\/\/doi.org\/10.1128\/AAC.04220-14","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"9829_CR405","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3892\/or.2012.1995","volume":"28","author":"CHENG-KUI CAI","year":"2012","unstructured":"Cai, C.-K., Zhao, G.-Y., Tian, L.-Y., Liu, L., Yan, K., Ma, Y.-L., \u2026 Ma, B.-A. (2012). miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncology reports, 28(5), 1764\u201370. https:\/\/doi.org\/10.3892\/or.2012.1995","journal-title":"Oncology Reports"},{"issue":"10070","key":"9829_CR406","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(16)31715-9","volume":"389","author":"Meike H van der Ree","year":"2017","unstructured":"van der Ree, M. H., de Vree, J. M., Stelma, F., Willemse, S., van der Valk, M., Rietdijk, S., \u2026 Reesink, H. W. (2017). Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial. Lancet (London, England), 389(10070), 709\u2013717. https:\/\/doi.org\/10.1016\/S0140-6736(16)31715-9","journal-title":"The Lancet"},{"issue":"12","key":"9829_CR407","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"Paul A. Northcott","year":"2012","unstructured":"Northcott, P. A., Jones, D. T. W., Kool, M., Robinson, G. W., Gilbertson, R. J., Cho, Y.-J., \u2026 Pfister, S. M. (2012). Medulloblastomics: the end of the beginning. Nature reviews. Cancer, 12(12), 818\u201334. https:\/\/doi.org\/10.1038\/nrc3410","journal-title":"Nature Reviews Cancer"},{"key":"9829_CR408","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-6563-2_1","volume-title":"Methods in Molecular Biology","author":"Marco F. Schmidt","year":"2016","unstructured":"Schmidt, M. F. (2017). miRNA targeting drugs: the next blockbusters? Methods in molecular biology (Clifton, N.J.), 1517, 3\u201322. https:\/\/doi.org\/10.1007\/978-1-4939-6563-2_1"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-019-09829-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-019-09829-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-019-09829-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:21:40Z","timestamp":1608078100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-019-09829-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":408,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9829"],"URL":"https:\/\/doi.org\/10.1007\/s10555-019-09829-x","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"17 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}